syndrome	score	normalized_score
#113100 BRACHYDACTYLY, TYPE C; BDC;;BRACHYDACTYLY, HAWS TYPE	17.563730239999998	100.0
#112500 BRACHYDACTYLY, TYPE A1; BDA1;;FARABEE-TYPE BRACHYDACTYLY	5.355661440000001	30.49273341606505
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	5.1080803999999995	29.083118051806288
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	4.1534091	23.647647983917114
SPONDYLOPERIPHERAL DYSPLASIA	3.55091243	20.217302255719456
POSTAXIAL OLIGODACTYLY, TETRAMELIC	3.3569802	19.113139146004105
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	3.2604167	18.56334990032277
606895 SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWEDZYGOMATIC ARCH	3.0451375	17.337646720768586
BRACHYDACTYLY, TYPE A2; BDA2	2.7665754399999996	15.751639328297951
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	2.6891679	15.310915524514456
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	2.6720278	15.213327485038853
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	2.668838	15.195166194946069
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	2.5522009	14.531086876907079
ACROCAPITOFEMORAL DYSPLASIA; ACFD	2.5198867	14.34710431990784
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	2.4356869000000003	13.867708435039141
ACHEIROPODY ACHEIROPODIA ACHEIROPODY, BRAZILIAN TYPE	2.4	13.664523237405405
FRONTOMETAPHYSEAL DYSPLASIA	2.39304773	13.624940131168858
#615072 BRACHYDACTYLY, TYPE A1, C; BDA1C	2.273975	12.9469934286579
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	2.24941864	12.807180532055359
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	2.1872711819999995	12.453340788727575
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	2.166667	12.336029820508108
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	2.1565693599999998	12.278538388665208
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	2.10075883	11.96077827029983
PSEUDOACHONDROPLASIA	2.0942612	11.923783680248555
HAIM-MUNK SYNDROME	2.0811595	11.849188478540423
SINGLETON-MERTEN SYNDROME 1; SGMRT1	2.0666667	11.76667297755081
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	2.0666667	11.76667297755081
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	2.0465185999999997	11.651958735617656
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	2.0323814000000002	11.571467861487722
MARSHALL-SMITH SYNDROME; MRSHSS	2.0314583	11.566212144237536
HAND OSTEOARTHRITIS	2.0294118	11.554560291401971
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	2.0138321	11.46585646945122
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	2.01054524	11.447142563264512
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	2.0	11.387102697837838
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	1.97017879	11.217314107415945
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	1.9364214	11.025114674045462
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	1.8976717	10.804491267340259
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	1.8478257999999999	10.520691076157181
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	1.833333	10.438175575167568
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	1.7417425	9.91670036034441
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	1.7193809899999999	9.789383954920046
BASAL CELL NEVUS SYNDROME	1.6499997	9.394358017650811
COFFIN-SIRIS SYNDROME 1; CSS1	1.6359979820000001	9.314638517244731
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	1.61812393	9.212871684369484
SYNDACTYLY, TYPE V	1.5921189	9.064810710734307
BRACHYDACTYLY, TYPE A1, D	1.56962422	8.936736095076805
SYNPOLYDACTYLY 1	1.5665754399999998	8.91937770959525
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	1.5532213000000001	8.843345227784598
WT LIMB-BLOOD SYNDROME	1.5512120699999998	8.831905573607807
#174500 POLYDACTYLY, PREAXIAL II; PPD2;;POLYDACTYLY OF TRIPHALANGEAL THUMB;;TRIPHALANGEAL THUMB-POLYDACTYLY SYNDROMETRIPHALANGEAL THUMB WITH POLYSYNDACTYLY, INCLUDED;;TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME, INCLUDED;;TPT-PS SYNDROME, INCLUDED;;TRIPHALANGEAL THUMB, INCLUDED; TPT, INCLUDED	1.5496952	8.823269196373174
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	1.5462134399999998	8.803445617028562
SYNDACTYLY, TYPE IV; SDTY4	1.537037	8.751199084688288
#228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY;;DU PAN SYNDROME	1.5247024	8.680971406219912
#150250 LARSEN SYNDROME; LRS	1.51976249	8.652845774975875
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	1.5	8.540327023378378
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	1.5	8.540327023378378
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	1.45	8.255649455932433
METAPHYSEAL ACROSCYPHODYSPLASIA	1.4392042	8.194183014279774
MUCOLIPIDOSIS III ALPHA/BETA	1.4117060000000001	8.037620600576933
#186570 TARSAL-CARPAL COALITION SYNDROME; TCC; SYNOSTOSIS OF TALUS AND CALCANEUS WITH SHORT STATURE, INCLUDED	1.4043149	7.9955389932019365
IVIC SYNDROME	1.3995884	7.968628422751273
Jawad syndrome	1.3930003819999999	7.931119203980669
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	1.372997	7.817228921411629
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	1.3656647899999999	7.775482607275571
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	1.3631579	7.761209500334481
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	1.359658682	7.7412865229704195
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	1.3484845	7.677665743971255
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	1.3283919000000002	7.563267494137967
BRACHYDACTYLY, TYPE A6	1.3257976	7.548496713873466
CRANIOSYNOSTOSIS, ADELAIDE TYPE	1.3214283	7.523619879964634
MESOMELIA-SYNOSTOSES SYNDROME	1.3125	7.472786145456081
CLEIDOCRANIAL DYSPLASIA; CCD	1.2973310999999998	7.386421234399464
#100800 ACHONDROPLASIA; ACH	1.28637279	7.324029533717093
Muenke syndrome	1.265383012	7.204523154871685
BRACHYDACTYLY, MONONEN TYPE	1.2625	7.1881085780101355
260150 PALANT CLEFT PALATE SYNDROME	1.25	7.116939186148649
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	1.25	7.116939186148649
POLYDACTYLY, PREAXIAL IV; PPD4	1.25	7.116939186148649
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	1.2449896	7.088412216470026
CATEL-MANZKE SYNDROME; CATMANS	1.219584822	6.94376880841914
TOWNES-BROCKS SYNDROME 1; TBS1	1.197070212	6.815580720283257
SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1	1.18254	6.732852212150578
ARTHROGRYPOSIS, DISTAL, TYPE 2A	1.1730396	6.6787611969153104
COFFIN-LOWRY SYNDROME; CLS	1.1708355300000002	6.666212211193699
#200700 CHONDRODYSPLASIA, GREBE TYPE;;ACHONDROGENESIS, BRAZILIAN;;GREBE CHONDRODYSPLASIA;;GREBE DYSPLASIA;;ACROMESOMELIC DYSPLASIA, GREBE TYPE; AMDG;;ACHONDROGENESIS, TYPE II, FORMERLY	1.1698009	6.660321492161565
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	1.1568223	6.586427166624487
ELLIS-VAN CREVELD SYNDROME	1.1555152	6.578985125656314
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	1.1181818000000001	6.366425495726586
ROBERTS SYNDROME; RBS	1.0952353	6.235778419698616
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	1.092803	6.221929994752641
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	1.08952599	6.203272170046721
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	1.0886405	6.198230587262766
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	1.0823745820000001	6.162555261381652
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	1.0819444299999998	6.16010616888181
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	1.079216882	6.14457673428717
TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS	1.0666667	6.073121628631893
BRACHYDACTYLY, TYPE A3	1.0665754399999998	6.072602035135788
OTOSCLEROSIS 7	1.06490139	6.063070745500132
CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS	1.0645162	6.060877646456041
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	1.06388844	6.057303462661244
TEMPLE-BARAITSER SYNDROME; TMBTS	1.061918982	6.046090252408705
DEAFNESS, AUTOSOMAL DOMINANT 1	1.05810013	6.0243474224527835
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	1.05	5.978228916364865
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	1.046676382	5.959305726617674
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	1.04602283	5.955584694746486
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	1.0416667	5.930782844908919
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	1.0416667	5.930782844908919
MULTIPLE SYNOSTOSES SYNDROME 2	1.04	5.921293402875676
ACROMICRIC DYSPLASIA	1.0398539	5.920461575023599
MARTSOLF SYNDROME	1.0398539	5.920461575023599
#185800 SYMPHALANGISM, PROXIMAL, 1A; SYM1A;;SYM1;;CUSHING SYMPHALANGISM;;HEREDITARY ABSENCE OF THE PROXIMAL INTERPHALANGEAL JOINTS	1.03942479	5.918018415204264
KEUTEL SYNDROME; KTLS	1.0361266	5.8992400010807735
RAPADILINO SYNDROME	1.0350514	5.8931182946704155
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	1.0349516399999998	5.892550305987847
DEAFNESS, AUTOSOMAL DOMINANT 6	1.03125	5.8714748285726355
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	1.031146882	5.870887720944638
BRACHYDACTYLY, LONG-THUMB TYPE	1.030303	5.866083035445209
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	1.0302556820000002	5.865813627982482
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	1.0285329	5.856004880202488
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	1.02383859	5.829277585169744
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	1.0238095	5.829111959761004
CHAR SYNDROME	1.022109322	5.819431909015702
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	1.02090984	5.812602596656599
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	1.0172414	5.791716145146171
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	1.0163068	5.7863949520554705
CHROMOSOME 9P DELETION SYNDROME	1.0159408620000001	5.7843114652619505
#615226 POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6	1.0126582	5.765621460603804
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	1.0104167	5.752859365255202
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	1.0104167	5.752859365255202
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	1.00934579	5.746762084180132
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	1.008595822	5.742492102862086
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	1.008595822	5.742492102862086
MENTAL RETARDATION, X-LINKED 9	1.0038926620000002	5.715714419899905
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	1.0027933	5.709455145901854
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	1.0027933	5.709455145901854
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	1.0027933	5.709455145901854
PEROXISOME BIOGENESIS DISORDER 11B	1.0027933	5.709455145901854
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	1.00254453	5.708038761132784
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	1.00254453	5.708038761132784
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	1.00254453	5.708038761132784
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	5.693551348918919
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	1.0	5.693551348918919
FRASER-LIKE SYNDROME	1.0	5.693551348918919
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	1.0	5.693551348918919
POROKERATOSIS PUNCTATA PALMARIS ET PLANTARIS	1.0	5.693551348918919
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	1.0	5.693551348918919
207620 APHALANGY WITH HEMIVERTEBRAE	1.0	5.693551348918919
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	1.0	5.693551348918919
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	1.0	5.693551348918919
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	1.0	5.693551348918919
KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL	1.0	5.693551348918919
SYMPHALANGISM, C. S. LEWIS TYPE	1.0	5.693551348918919
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	1.0	5.693551348918919
DYSTELEPHALANGY	1.0	5.693551348918919
MAL DE MELEDA	1.0	5.693551348918919
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	1.0	5.693551348918919
RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARYDIASTEMA	1.0	5.693551348918919
SECOND METATARSAL-METACARPAL SYNDROME	1.0	5.693551348918919
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	1.0	5.693551348918919
MYOPATHY, DISTAL, 1; MPD1	1.0	5.693551348918919
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	1.0	5.693551348918919
RADIAL LOOP, PLAIN, ON RIGHT INDEX FINGER	1.0	5.693551348918919
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	1.0	5.693551348918919
ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSISDIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS, INCLUDED	1.0	5.693551348918919
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	1.0	5.693551348918919
PARANA HARD-SKIN SYNDROME	1.0	5.693551348918919
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	1.0	5.693551348918919
Ullrich congenital muscular dystrophy 1	1.0	5.693551348918919
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.9999125999999999	5.693053732531023
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.9791663	5.574933608180947
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.97707394	5.563020649080523
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.933333	5.313979361140541
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.9306465999999999	5.298684204796805
BRACHYDACTYLY, TYPE B2	0.9103901299999998	5.183352952703969
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.9085811819999999	5.173053614378445
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.89861342	5.116301649597643
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.895833	5.100471185556081
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.8912852	5.074578052731469
NASODIGITOACOUSTIC SYNDROME	0.87734713	4.995220935481642
Orofaciodigital syndrome XVII	0.87250878	4.9676735413126005
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.833333	4.74462422624865
OMODYSPLASIA 1; OMOD1	0.833333	4.74462422624865
PALLISTER-HALL SYNDROME	0.830168782	4.726608588586476
%118651 CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE;;CHONDRODYSPLASIA PUNCTATA, MT TYPE	0.8166667	4.649733791402162
OROFACIODIGITAL SYNDROME VI	0.8147705719999999	4.638938089270039
KOOLEN-DE VRIES SYNDROME; KDVS	0.800961262	4.5603140736919
LERI-WEILL DYSCHONDROSTEOSIS	0.7958337	4.531120036150135
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.7785485	4.432705862373801
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.7720689819999998	4.395814393924556
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.7696078	4.381801527828522
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.755869012	4.303579032878611
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.7259615	4.133299077588202
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.7	3.985485944243243
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.67623024	3.850151595131764
DESBUQUOIS DYSPLASIA 1	0.6625	3.771977768658784
SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL	0.6615276999999999	3.76644192868223
HAND-FOOT-GENITAL SYNDROME; HFG	0.66049864	3.7605829227311114
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.65021879	3.7020540688969277
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.64876607	3.6937829329813257
#607641 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B;;HMN VIIB;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB;;DHMN7B;;NEUROPATHY, DISTAL HEREDITARY MOTOR, WITH VOCAL CORD PARALYSIS, TYPEVIIB;;LOWER MOTOR NEURON DISEASE, DYNACTIN TYPE	0.642857	3.6601393395119697
DUANE-RADIAL RAY SYNDROME; DRRS	0.64002143	3.6439948761135152
POLYDACTYLY, PREAXIAL I; PPD1	0.637037	3.6270028706612614
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.6358215	3.6200823589966507
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.629211982	3.5824507288720464
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.626984	3.569765598950579
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.614001782	3.4958506741447204
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.6139043	3.495295655372124
SYMPHALANGISM, DISTAL	0.611111	3.479391858389189
LICHTENSTEIN SYNDROME	0.610989	3.4786972451246214
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.5947741	3.386376879357036
FEINGOLD SYNDROME 1; FGLDS1	0.5861263	3.337140186001855
CRANIOACROFACIAL SYNDROME	0.583333	3.3212363890189196
#615298 SYMPHALANGISM, PROXIMAL, 1B; SYM1B	0.583333	3.3212363890189196
TUKEL SYNDROME	0.573333	3.2643008755297305
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.57304524	3.2626624991935658
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.5717703	3.255403562836775
HOLT-ORAM SYNDROME	0.5629891	3.205407349731648
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.5625	3.2026226337668917
OMODYSPLASIA	0.5625	3.2026226337668917
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.5625	3.2026226337668917
#156500 METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS;;SPONDYLOMETAPHYSEAL DYSPLASIA, JAPANESE TYPE	0.5586298	3.1805874513363057
SYNDACTYLY, TYPE III	0.5526316	3.1464363916352203
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.5505504999999999	3.134587541922985
MIRAGE SYNDROME; MIRAGE	0.5462983819999999	3.1103778897483227
CRANIOECTODERMAL DYSPLASIA 1	0.5436844	3.095495049006173
TRIPHALANGEAL THUMB WITH DOUBLE PHALANGES	0.537037	3.0576477357693697
WEILL-MARCHESANI SYNDROME 1; WMS1	0.5350136	3.0461274039699666
WEILL-MARCHESANI SYNDROME 2; WMS2	0.5350136	3.0461274039699666
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.5322581	3.0304388232280206
#604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA	0.5294118	3.014233268023593
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.529074282	3.0123115919594086
CHARGE SYNDROME	0.5265155	2.997743035251719
TERMINAL OSSEOUS DYSPLASIA; TOD	0.5238095	2.9823362853015447
ADACTYLIA, UNILATERAL	0.5181818	2.9502946863752335
LARSEN-LIKE SYNDROME	0.517941612	2.9489271636638392
HYPOGLOSSIA-HYPODACTYLIA	0.515873	2.9371494150208495
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.5153366819999999	2.9340958609484997
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.5126582	2.918845786144345
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.5120482	2.9153727198215043
DEAFNESS AND MYOPIA; DFNMYP	0.50934579	2.8999864097206727
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.503892662	2.8689387454404454
POTOCKI-LUPSKI SYNDROME	0.503637182	2.8674841569418232
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.50304878	2.8641340599410166
CAMPOMELIC DYSPLASIA	0.5027933	2.862679471442395
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.5027933	2.862679471442395
SCLEROSTEOSIS 1; SOST1	0.5027933	2.862679471442395
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.5027933	2.862679471442395
MORQUIO SYNDROME A	0.5027933	2.862679471442395
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.50254453	2.861263086673324
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.500843882	2.851580359958888
SPINAL DYSPLASIA, ANHALT TYPE	0.5	2.8467756744594594
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.5	2.8467756744594594
DEAFNESS, UNILATERAL	0.5	2.8467756744594594
TRICHOHEPATOENTERIC SYNDROME 1	0.5	2.8467756744594594
SCALP DEFECTS AND POSTAXIAL POLYDACTYLY	0.5	2.8467756744594594
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.5	2.8467756744594594
OSTEOARTHRITIS OF DISTAL INTERPHALANGEAL JOINTS	0.5	2.8467756744594594
OSSICULAR MALFORMATIONS, FAMILIAL	0.5	2.8467756744594594
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.5	2.8467756744594594
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.5	2.8467756744594594
190410 TRIGGER THUMB	0.5	2.8467756744594594
POLYDACTYLY, POSTAXIAL, TYPE A10; PAPA10	0.5	2.8467756744594594
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.5	2.8467756744594594
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.5	2.8467756744594594
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.5	2.8467756744594594
118610 CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION;;FAMILIAL APATITE DISEASE	0.5	2.8467756744594594
#200600 ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE	0.5	2.8467756744594594
EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA	0.5	2.8467756744594594
EPIDERMOLYSIS BULLOSA SIMPLEX, WEBER-COCKAYNE TYPE	0.5	2.8467756744594594
STORM SYNDROME	0.5	2.8467756744594594
ROMBO SYNDROME	0.5	2.8467756744594594
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	2.8467756744594594
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.5	2.8467756744594594
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.5	2.8467756744594594
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.5	2.8467756744594594
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.5	2.8467756744594594
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.5	2.8467756744594594
IMMUNODEFICIENCY 36; IMD36	0.5	2.8467756744594594
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.5	2.8467756744594594
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.49008562200000005	2.790327654223868
ACROCALLOSAL SYNDROME; ACLS	0.48895564	2.783894043683514
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.4833337	2.751885239612972
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.4833337	2.751885239612972
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.458333	2.609542470404055
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.44862262999999997	2.554255980192053
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	0.44576699999999997	2.5379973041535395
PELGER-HUET ANOMALY; PHA	0.44251058199999993	2.5194567210569954
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.441251552	2.5122883691021665
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.43287	2.4645675724065326
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.4281480020000001	2.4376826343240405
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.425227982	2.42105735051417
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.4240527	2.4143658220977096
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.42077670000000006	2.3957137478786517
STUVE-WIEDEMANN SYNDROME	0.4204584	2.39390149048429
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.4196428	2.3892578300041123
COCKAYNE SYNDROME A; CSA	0.41921083	2.3867983866279197
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.41751088199999997	2.377119645399427
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.415362082	2.364885342260871
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.41246479999999996	2.348389518421572
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.41166769999999997	2.3438511886413487
SECKEL SYNDROME 1; SCKL1	0.40665614	2.3153176144431606
3MC SYNDROME 1	0.40306233	2.2948560726699028
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.39456329999999995	2.2464664089489
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.392857	2.2367515022822397
#270685 SPASTIC PARAPLEGIA 17; SPG17;;SPASTIC PARAPLEGIA WITH AMYOTROPHY OF HANDS AND FEET;;SILVER SYNDROME;;SILVER SPASTIC PARAPLEGIA SYNDROME	0.392857	2.2367515022822397
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.392857	2.2367515022822397
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.392857	2.2367515022822397
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.38792473	2.2086693697705075
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.3874472	2.205950528194858
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.38744579999999995	2.2059425572229694
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.38434579	2.1882924911058077
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.3838235	2.1853188061717805
CAMPTOBRACHYDACTYLY	0.383333	2.1825261192351357
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	0.37315770000000004	2.1245925261944816
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.3688557	2.100098868291432
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.3655911	2.0815117005577517
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.364583	2.0757720314429062
SAY SYNDROME	0.3605327	2.0527114404143796
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.3596488	2.0476789103770705
#614976 CARPENTER SYNDROME 2; CRPT2	0.356329212	2.0287786656418154
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.353044782	2.010078594784886
Temtamy preaxial brachydactyly syndrome	0.351260582	1.9999201604681445
ZUNICH NEUROECTODERMAL SYNDROME	0.34966743	1.9908494677495119
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.3478056	1.9802490430415538
DUPUYTREN CONTRACTUREDUPUYTREN CONTRACTURE 1, INCLUDED	0.3464909	1.97276373108313
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.344322	1.9604149875624601
YUNIS-VARON SYNDROME	0.3423596	1.9492419623953414
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.3390248	1.930255107356967
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.33834559999999997	1.9263880472807808
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.33788042999999995	1.9237395779998043
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.334176882	1.9026532372886187
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.334176882	1.9026532372886187
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.334176882	1.9026532372886187
AICARDI-GOUTIERES SYNDROME 5	0.334176882	1.9026532372886187
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.33406513	1.902016971538274
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.33373812199999997	1.9001551346987666
POROKERATOSIS PLANTARIS, PALMARIS, ET DISSEMINATA	0.333333	1.8978485517891899
%107000 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6;;ANONYCHIA/HYPONYCHIA AND ONYCHODYSTROPHY;;ANONYCHIA, PARTIAL	0.333333	1.8978485517891899
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.333333	1.8978485517891899
#309630 METACARPAL 4-5 FUSION; MF4	0.333333	1.8978485517891899
#131960 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP;;SPECKLED HYPERPIGMENTATION WITH PUNCTATE PALMOPLANTAR KERATOSES ANDCHILDHOOD BLISTERING	0.333333	1.8978485517891899
#615575 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D;;HMN IID;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; DHMN2D;;SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT	0.333333	1.8978485517891899
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.333333	1.8978485517891899
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.333333	1.8978485517891899
PEYRONIE DISEASE	0.333333	1.8978485517891899
PSEUDODIASTROPHIC DYSPLASIA	0.333333	1.8978485517891899
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.333333	1.8978485517891899
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.333333	1.8978485517891899
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	1.8978485517891899
PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A	0.333333	1.8978485517891899
DERMATOGLYPHICS--ARCH ON ANY DIGIT	0.333333	1.8978485517891899
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.333333	1.8978485517891899
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.333333	1.8978485517891899
REYNOLDS SYNDROME	0.333333	1.8978485517891899
DERMAL RIDGES-OFF-THE-END	0.333333	1.8978485517891899
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.333333	1.8978485517891899
#601369 DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9	0.333333	1.8978485517891899
TURNPENNY-FRY SYNDROME; TPFS	0.33274427200000006	1.894496598690644
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.3318024	1.8891340020945349
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.3261737	1.8570867096168748
KAPUR-TORIELLO SYNDROME	0.3209384900000001	1.8272797726595014
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.31869400000000003	1.8145006535923662
SILVER-RUSSELL SYNDROME; SRS	0.317419322	1.8072432089460286
RHIZOMELIC SYNDROME	0.309524	1.7622907877227798
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.30882350000000003	1.7583024550028619
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.3080121	1.753682707438349
CURRY-JONES SYNDROME	0.307488682	1.7507026001784005
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.3055556	1.7396964985497296
MICROPHTHALMIA, SYNDROMIC 1	0.3004443	1.7105950495400004
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.29992838200000005	1.707657643915169
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.2977622	1.6953243754670648
608028 THAI SYMPHALANGISM SYNDROME	0.2969292	1.6905816471934156
#184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES;;ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, ANDSYNDACTYLY;;TEUNISSEN-CREMERS SYNDROME;;STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	0.29410509	1.6745024318934203
112450 BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION;;CHRISTIAN BRACHYDACTYLY	0.29375	1.6724807087449327
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.2916667	1.6606193332197297
FONTAINE PROGEROID SYNDROME; FPS	0.29116399000000004	1.657757128021115
SYNPOLYDACTYLY 2	0.29	1.6511298911864865
WIEACKER-WOLFF SYNDROME	0.286150762	1.6292140569792766
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.27972753	1.5926430557612572
CRI-DU-CHAT SYNDROME	0.27724778	1.5785244718037759
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.275403682	1.5680250051483369
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.27296639	1.5541481579940277
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.27226386999999996	1.5501483243003849
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.27140003	1.5452300069031353
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.2681818	1.5269068491455038
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.267406162	1.522490714364331
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.2672414	1.5215526334569807
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.262892082	1.4967895680912031
%263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	0.2626582	1.4954579489146154
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.2626582	1.4954579489146154
OSTEOGENESIS IMPERFECTA, TYPE V	0.2625	1.4945572290912164
268650 RUDIGER SYNDROME	0.260989	1.485954273003
BRACHYDACTYLY, TYPE A4	0.2588235	1.4736248875569158
TALONAVICULAR COALITION	0.25775194	1.4675239056734684
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.25744112	1.4657542360431974
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.25669948200000003	1.4615316820078879
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.25502513	1.4519986729197225
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.2527933	1.439291634212665
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.25181200000000004	1.433704552273971
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.25126057	1.4305649572536365
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.25	1.4233878372297297
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.25	1.4233878372297297
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.25	1.4233878372297297
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.25	1.4233878372297297
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	1.4233878372297297
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	1.4233878372297297
BRACHYDACTYLY, TYPE D	0.25	1.4233878372297297
FECHTNER SYNDROME	0.25	1.4233878372297297
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.25	1.4233878372297297
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.25	1.4233878372297297
SONODA SYNDROME	0.25	1.4233878372297297
FINGERPRINTS, ABSENCE OF	0.25	1.4233878372297297
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.25	1.4233878372297297
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.25	1.4233878372297297
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3	0.25	1.4233878372297297
HYPERPARATHYROIDISM 2	0.25	1.4233878372297297
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.25	1.4233878372297297
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.25	1.4233878372297297
DARIER-WHITE DISEASE; DAR	0.25	1.4233878372297297
DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH	0.25	1.4233878372297297
DYSTONIA 6, TORSION	0.25	1.4233878372297297
KLEEBLATTSCHAEDEL SYNDROME	0.25	1.4233878372297297
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.25	1.4233878372297297
#615726 PACHYONYCHIA CONGENITA 3; PC3	0.25	1.4233878372297297
#612643 DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B	0.25	1.4233878372297297
MOEBIUS SYNDROME; MBS	0.24916397999999998	1.4186279144310066
SMITH-KINGSMORE SYNDROME; SKS	0.24848520000000002	1.4147632456463877
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.24799903	1.4119952117870835
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.2434783	1.3862562033974852
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.2413258	1.3740008341189374
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.24080183	1.3710175840186443
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.24043979999999998	1.368956347623795
Pierpont syndrome	0.23912806200000003	1.361487899964467
LOWE OCULOCEREBRORENAL SYNDROME	0.2369674	1.349186059919809
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.23688800000000002	1.348733991942705
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.2294118	1.3061678633479172
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.2294118	1.3061678633479172
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.22912804000000003	1.3045522612171483
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.228494582	1.3009456355667646
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.22689192	1.2918207971748035
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.22486399999999995	1.2802747305233035
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.22280700000000003	1.2685630953985778
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.21957700000000002	1.2501729245415696
FLOATING-HARBOR SYNDROME	0.21947903000000002	1.2496151273159162
BRACHYDACTYLY, TYPE B1	0.219101	1.247462794099484
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.216856672	1.2346845973876677
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.216575	1.2330808833921147
ANONYCHIA-ECTRODACTYLY	0.215873	1.229084010345174
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.21517147999999997	1.22508987020288
ELSAHY-WATERS SYNDROME; ESWS	0.214357382	1.2204547614368282
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.21428570000000002	1.220046636289035
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.21290903	1.2122084949535186
WEAVER SYNDROME	0.212138362	1.20782065712255
Contractural arachnodactyly, congenital	0.2120574	1.2073596958182389
OCULODENTODIGITAL DYSPLASIA; ODDD	0.21102628999999998	1.201489018086855
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.21029647	1.197333750441387
NAIL-PATELLA SYNDROME	0.20399047	1.1614302156351044
3MC SYNDROME 3	0.2027933	1.154614066766719
CORNELIA DE LANGE SYNDROME 3	0.200522722	1.1416864143319934
46,XY SEX REVERSAL 3	0.2	1.1387102697837839
#300758 HYPOSPADIAS 2, X-LINKED; HYSP2	0.2	1.1387102697837839
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.2	1.1387102697837839
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.2	1.1387102697837839
PYCNODYSOSTOSIS	0.2	1.1387102697837839
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.2	1.1387102697837839
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.2	1.1387102697837839
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.2	1.1387102697837839
46,XX SEX REVERSAL 4; SRXX4	0.2	1.1387102697837839
#615706 AURICULOCONDYLAR SYNDROME 3; ARCND3	0.2	1.1387102697837839
Leri-Weill dyschondrostosis (LWD) - SHOX deletion	0.2	1.1387102697837839
176800 PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF	0.2	1.1387102697837839
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.19693408199999995	1.1212543082192088
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.19609019999999996	1.1164496227197804
FANCONI ANEMIA	0.19609019999999996	1.1164496227197804
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.19609019999999996	1.1164496227197804
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.1952384	1.1115998556807716
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.19418896199999996	1.1056248265402646
COSTELLO SYNDROME; CSTLO	0.19251058199999999	1.096068883827266
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.18953559999999997	1.0791306710481565
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.18923979	1.0774464616236328
Aarskog-Scott syndrome	0.18907168200000002	1.076489330093469
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.1878976	1.0698046339386276
Diamond-Blackfan anemia 1	0.1874769	1.0674093568861374
FOCAL DERMAL HYPOPLASIA; FDH	0.1840268	1.047766035377232
TETRAMELIC MONODACTYLY	0.18254	1.0393008632316596
FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY	0.18254	1.0393008632316596
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.18254	1.0393008632316596
HAMAMY SYNDROME; HMMS	0.18125973	1.0320115802461791
#278250 WRINKLY SKIN SYNDROME; WSS	0.18082647999999998	1.0295448491242598
FRYNS SYNDROME; FRNS	0.18064739999999999	1.0285252479486955
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.1794118	1.0214902959019714
PRADER-WILLI SYNDROME; PWS	0.178829462	1.0181747245965445
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.17871520000000002	1.0175241680323144
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.1770837	1.0082351390065531
Myhre syndrome	0.1768988	1.007182401362138
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.175	0.9963714860608107
SCHAAF-YANG SYNDROME; SHFYNG	0.173672112	0.9888110875471975
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.1721491	0.9801397405201778
PETERS-PLUS SYNDROME; PTRPLS	0.17211622199999999	0.9799525479389279
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.17203764000000002	0.9795051372868275
COHEN SYNDROME	0.17196740000000002	0.9791052222400793
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.171469112	0.9762681939255292
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.171305122	0.9753345084398201
CORNELIA DE LANGE SYNDROME 1	0.17065654	0.9716417735188354
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.16988399999999998	0.9672432773597415
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.16768227	0.9547076145482863
NAVAJO NEUROHEPATOPATHY	0.167510882	0.9537318081696978
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.166667	0.9489271226702696
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS	0.166667	0.9489271226702696
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.166667	0.9489271226702696
SECKEL SYNDROME 7; SCKL7	0.166667	0.9489271226702696
FINGERS, RELATIVE LENGTH OF	0.166667	0.9489271226702696
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.166667	0.9489271226702696
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.166667	0.9489271226702696
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.166667	0.9489271226702696
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.166667	0.9489271226702696
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.166667	0.9489271226702696
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.166667	0.9489271226702696
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.166667	0.9489271226702696
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.166667	0.9489271226702696
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.16403510000000002	0.9339422648750499
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.16305494	0.9283616735848935
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.162821272	0.9270312728282942
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.1624648	0.9250016811918423
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.161405382	0.9189698304088733
COFFIN-SIRIS SYNDROME 2; CSS2	0.160263162	0.9124665421871112
COFFIN-SIRIS SYNDROME 4; CSS4	0.16000768199999998	0.9110119536884894
COFFIN-SIRIS SYNDROME 3; CSS3	0.16000768199999998	0.9110119536884894
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.15936683000000001	0.9073632299194322
DESBUQUOIS DYSPLASIA 2; DBQD2	0.15919186200000002	0.9063670406270146
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.15872999999999998	0.9037374056138999
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.15734979999999998	0.895879166042122
NANCE-HORAN SYNDROME	0.1571427	0.8947000315577609
600736 VELOFACIOSKELETAL SYNDROME	0.15365420000000002	0.8748380776770575
WAHAB SYNDROME	0.1533991	0.8733856527279482
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.151111	0.8603582378864867
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.149200252	0.8494792960336428
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.14869907999999998	0.8466258475170022
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.14837783000000002	0.8447967941461622
#300867 KABUKI SYNDROME 2; KABUK2	0.147177882	0.8379648285921295
KABUKI SYNDROME 1	0.147177882	0.8379648285921295
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.14590577999999998	0.8307220505340669
PSEUDOARTHROGRYPOSIS	0.1458333	0.8303093819322973
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.1458333	0.8303093819322973
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.1458333	0.8303093819322973
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.14540152999999997	0.8278510772663745
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.14540152999999997	0.8278510772663745
MELNICK-NEEDLES SYNDROME	0.1445595	0.8230569362240446
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.14287227	0.8134506055816081
MYOPATHY, SCAPULOHUMEROPERONEAL	0.14285699999999998	0.8133636650525099
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.14285699999999998	0.8133636650525099
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.14285699999999998	0.8133636650525099
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.14285699999999998	0.8133636650525099
SPINAL MUSCULAR ATROPHY, SEGMENTAL	0.14285699999999998	0.8133636650525099
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.14285699999999998	0.8133636650525099
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.14209773	0.8090407223198164
C SYNDROME	0.141462682	0.8054250439227882
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.140843882	0.8019018743480771
PACHYONYCHIA CONGENITA 2	0.14052279999999998	0.8000737774938633
BRANCHIOOCULOFACIAL SYNDROME	0.13976935999999998	0.7957840281655338
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.1394928	0.7942094196044769
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.139272862	0.7929571913078983
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.138981882	0.79130048173639
FOUNTAIN SYNDROME	0.13801692999999998	0.785806477975148
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.13703700000000002	0.780227196201802
RENPENNING SYNDROME 1; RENS1	0.13644824000000003	0.7768750609096126
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.13553706999999998	0.7716872677270179
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.1334226	0.7596484242062694
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.133194912	0.7583520708867367
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.132208582	0.7527363503847574
CODAS SYNDROME	0.132194702	0.7526573238920345
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.12977729999999998	0.7388937214740552
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.12952852999999998	0.7374773367049846
PETTIGREW SYNDROME	0.128388412	0.730986016328158
184705 STEINFELD SYNDROME	0.1277933	0.7275977155978001
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.12754453	0.7261813308287295
DEAFNESS, X-LINKED 4	0.12754453	0.7261813308287295
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.1274989	0.7259215340806783
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.12698399999999999	0.72298992449112
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.12698399999999999	0.72298992449112
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.12698399999999999	0.72298992449112
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.12698399999999999	0.72298992449112
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.126356882	0.7194193959562887
EHLERS-DANLOS SYNDROME, TYPE VI	0.1256038	0.7151316849193421
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.1256038	0.7151316849193421
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.1250897	0.7122046301708629
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.125	0.7116939186148649
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.125	0.7116939186148649
THUMB DEFORMITY	0.125	0.7116939186148649
#612644 DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B	0.125	0.7116939186148649
#300455 RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITHOR WITHOUT DEAFNESS	0.125	0.7116939186148649
DIGITOTALAR DYSMORPHISM	0.1238095	0.704915745733977
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.12372158999999999	0.7044152256348934
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.1233397	0.7022409153102548
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.1231672	0.7012587777025663
ODONTOCHONDRODYSPLASIA; ODCD	0.1229167	0.6998325430896621
LUSCAN-LUMISH SYNDROME; LLS	0.12084186200000001	0.688019346395974
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.1188679	0.6767804923881592
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.11838546200000001	0.6740337068624894
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.11838546200000001	0.6740337068624894
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.117647	0.6698292355462641
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.11734	0.668081315282146
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.11695430000000001	0.665885312526868
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.11640908999999999	0.6627811313959238
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.115685382	0.6586606627363004
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.11533668200000001	0.6566753213809325
WITTEVEEN-KOLK SYNDROME	0.115303062	0.6564839041845818
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.1145268	0.6520642166273672
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.1144928	0.6518706358815041
BRITTLE CORNEA SYNDROME	0.11390429999999999	0.6485199809126652
KEIPERT SYNDROME; KPTS	0.11306143	0.643721057287202
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.112365012	0.6397559656438906
NOONAN SYNDROME 8; NS8	0.11111099999999999	0.63261618392973
CRANIOFACIOFRONTODIGITAL SYNDROME	0.11111099999999999	0.63261618392973
KERATOLYTIC WINTER ERYTHEMA; KWE	0.11111099999999999	0.63261618392973
CHROMOSOME 2q35 DUPLICATION SYNDROME	0.11111099999999999	0.63261618392973
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.11111099999999999	0.63261618392973
PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN	0.11111099999999999	0.63261618392973
HYPERHIDROSIS PALMARIS ET PLANTARIS	0.11111099999999999	0.63261618392973
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.11111099999999999	0.63261618392973
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.11111099999999999	0.63261618392973
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.11111099999999999	0.63261618392973
BOOK SYNDROME	0.11111099999999999	0.63261618392973
%164800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5;;ONYCHOLYSIS, PARTIAL, WITH SCLERONYCHIA;;ONYCHOLYSIS, HEREDITARY DISTAL	0.11111099999999999	0.63261618392973
FILIPPI SYNDROME; FLPIS	0.110989	0.631921570665162
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.109453122	0.623176970406487
BOHRING-OPITZ SYNDROME	0.10897058200000001	0.6204296041385797
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.108845	0.6197145965730798
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.1088235	0.619592185219078
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.108765382	0.6192612874017814
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.10817698	0.615911190400975
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.1077733	0.6136128175924433
CHROMOSOME 17q12 DELETION SYNDROME	0.10666178	0.607284321397093
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.1061975	0.6046409193768169
CRANIOECTODERMAL DYSPLASIA 4	0.1060606	0.6038614721971499
Congenital disorder of glycosylation, type IIh	0.10586901200000001	0.6027706560813133
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.10578333999999999	0.6022828781501486
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.1055556	0.6009862287659459
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.10510359999999999	0.5984127435562344
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.1050697	0.5982197321655062
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.104947772	0.5975255288366351
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.104398512	0.5943982888227279
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.10419632199999998	0.5932471096754899
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.103838782	0.5912114373261975
COHEN-GIBSON SYNDROME; COGIS	0.10196196200000002	0.5805256662835196
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.10129869999999999	0.5767493500287328
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.1010101	0.575106191109435
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.1002959	0.571039856736037
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.10006266	0.5697118928194151
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.1	0.5693551348918919
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.1	0.5693551348918919
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.1	0.5693551348918919
SCHNECKENBECKEN DYSPLASIA	0.1	0.5693551348918919
GRANGE SYNDROME; GRNG	0.1	0.5693551348918919
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.1	0.5693551348918919
CHROMOSOME 1P36 DELETION SYNDROME	0.099976022	0.5692186149176475
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.09880333	0.5625418327991811
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.09866998200000002	0.5617826091139055
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.09856554	0.5611879632239216
VAN BOGAERT-HOZAY SYNDROME	0.0960785	0.5470278732771063
OROFACIODIGITAL SYNDROME X	0.0958605	0.5457866790830421
TIETZ SYNDROME	0.0954545	0.543475097235381
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.09480176200000001	0.5397586999149904
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.09480029000000001	0.5397503190074048
ZIMMERMANN-LABAND SYNDROME 1	0.0939583	0.5349564057071284
KYPHOMELIC DYSPLASIA	0.09375000000000001	0.5337704389611487
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.092803	0.5283786458337224
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0910816	0.5185777665416934
ALSTROM SYNDROME; ALMS	0.09091738199999999	0.5176427829262766
BROAD TERMINAL PHALANGES, FAMILIAL	0.0909091	0.5175956289340049
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0902326	0.5137439414464613
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.089527	0.5097265716146641
DEAFNESS, AUTOSOMAL DOMINANT 50	0.08935013000000001	0.5087195531875808
VELOCARDIOFACIAL SYNDROME	0.0891265	0.5074463042994221
MUCOLIPIDOSIS III GAMMA	0.0882353	0.5023722113372655
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.087915622	0.5005521082291459
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.08780866200000001	0.49994312597686547
AL KAISSI SYNDROME; ALKAS	0.087800762	0.499898146921209
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.087800762	0.499898146921209
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.087508562	0.4982344912170549
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.0868427	0.494443371728761
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.08680560000000001	0.4942321409737162
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0862745	0.49120829585230535
OTODENTAL DYSPLASIA	0.08587783000000002	0.4889498348387297
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.08587783000000002	0.4889498348387297
JABERI-ELAHI SYNDROME; JABELS	0.085811282	0.4885709403835618
MEND SYNDROME; MEND	0.08475988200000001	0.4825847404953084
ACRORENAL-MANDIBULAR SYNDROME	0.08474090000000001	0.48247666550360324
RUVALCABA SYNDROME	0.0841223	0.478954634639162
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.0838185	0.4772249337393604
STIFF SKIN SYNDROME	0.08333330000000001	0.47446242262486504
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.08333330000000001	0.47446242262486504
RESTRICTIVE DERMOPATHY, LETHAL	0.08333330000000001	0.47446242262486504
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.08333330000000001	0.47446242262486504
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.08333330000000001	0.47446242262486504
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.08333330000000001	0.47446242262486504
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.08333330000000001	0.47446242262486504
FASCIAL DYSTROPHY, CONGENITAL	0.08333330000000001	0.47446242262486504
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.08333330000000001	0.47446242262486504
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0824609	0.46949536842806816
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0822581	0.4683407162145073
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.08214226	0.4676811752262485
DEAFNESS, AUTOSOMAL DOMINANT 20	0.08125	0.46260104709966215
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.08125	0.46260104709966215
WIEDEMANN-STEINER SYNDROME; WDSTS	0.08068460200000002	0.4593819245540863
HYPERTRYPTOPHANEMIA; HYPTRP	0.080540712	0.4585626794504902
OROFACIODIGITAL SYNDROME IV; OFD4	0.080303	0.45720925397223594
HEART AND BRAIN MALFORMATION SYNDROME	0.08020898200000001	0.45667395766151336
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.07951193000000001	0.4527052563066467
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.07930538200000001	0.45152926466263016
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.07930538200000001	0.45152926466263016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.078779082	0.4485327485876941
VAN MALDERGEM SYNDROME 1; VMLDS1	0.07855702	0.44726842718805054
VAN MALDERGEM SYNDROME 2; VMLDS2	0.07855702	0.44726842718805054
TARP SYNDROME; TARPS	0.078499582	0.4469414009856713
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.07827680000000001	0.4456729802290565
PALLISTER-KILLIAN SYNDROME	0.07788994	0.44347037295421365
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.077647762	0.4420915200756352
SATOYOSHI SYNDROME	0.0770834	0.43887829604925654
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.07699649	0.438383469501522
MARFANOID HABITUS WITH SITUS INVERSUS	0.0769928	0.4383624602970445
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.0769928	0.4383624602970445
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.07692310000000001	0.43796561976802495
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.07692310000000001	0.43796561976802495
#601869 DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15;;DEAFNESS, AUTOSOMAL RECESSIVE 72; DFNB72;;DEAFNESS, AUTOSOMAL RECESSIVE 95; DFNB95	0.07692310000000001	0.43796561976802495
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.07692310000000001	0.43796561976802495
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.07692310000000001	0.43796561976802495
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.07692310000000001	0.43796561976802495
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.07638508199999999	0.43490238665838216
#606835 DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB	0.07617370000000001	0.43369887238714516
MENTAL RETARDATION, X-LINKED 91; MRX91	0.075742012	0.4312410345924329
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.07554280000000001	0.4301068108411122
Glycosylphosphatidylinositol biosynthesis defect 18	0.075262522	0.42851103365613985
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.07521879000000001	0.428262043268549
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0748663	0.42625512335356847
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0748663	0.42625512335356847
SPLIT-HAND/FOOT MALFORMATION 6	0.0746965	0.425288358334522
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.07456360000000001	0.4245316853602508
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.07454820000000001	0.4244440046694774
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0744235	0.4237340188162672
ACROCRANIOFACIAL DYSOSTOSIS	0.07439032000000001	0.4235451067825101
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.074075062	0.42175016917135255
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.07389704	0.42073659177311534
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.073489	0.41841339508070247
TEEBI-SHALTOUT SYNDROME; TBSH	0.073489	0.41841339508070247
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0732283	0.41692908624403924
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.07310520000000001	0.4162282100729874
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.07161363000000001	0.40773587968748043
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.070559362	0.40173335069395827
SHASHI-PENA SYNDROME; SHAPNS	0.070559362	0.40173335069395827
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.0701315	0.39929729642670714
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.06961880000000001	0.3963782126501165
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0696078	0.3963155835852783
POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	0.069303	0.3945801891341279
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.06921123	0.39405769192683754
PHELAN-MCDERMID SYNDROME; PHMDS	0.067951402	0.3868847965180317
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.0675439	0.3845646629562446
KETOADIPICACIDURIA	0.067510582	0.3843749652124013
AU-KLINE SYNDROME; AUKS	0.067510582	0.3843749652124013
CHROMOSOME 17P13.1 DELETION SYNDROME	0.067121382	0.382159035027402
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0666667	0.37957027971297286
PULMONARY ARTERIOVENOUS FISTULAS	0.0666667	0.37957027971297286
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.0666667	0.37957027971297286
NOONAN SYNDROME 7; NS7	0.0666667	0.37957027971297286
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.0666667	0.37957027971297286
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0666667	0.37957027971297286
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.0666667	0.37957027971297286
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.0666667	0.37957027971297286
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.0666667	0.37957027971297286
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.0666667	0.37957027971297286
AASE-SMITH SYNDROME I	0.0666667	0.37957027971297286
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.0666667	0.37957027971297286
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.0666667	0.37957027971297286
173700 POIKILODERMA, HEREDITARY SCLEROSING	0.0666667	0.37957027971297286
ACROOSTEOLYSIS	0.0666667	0.37957027971297286
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.0666667	0.37957027971297286
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0666667	0.37957027971297286
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.0666667	0.37957027971297286
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.0666667	0.37957027971297286
PEUTZ-JEGHERS SYNDROME	0.0666667	0.37957027971297286
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.0666667	0.37957027971297286
CLEIDORHIZOMELIC SYNDROME	0.06657544	0.37905068621687055
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.06654460000000001	0.37887509709327
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.0664488	0.37832965487404346
3MC SYNDROME 2	0.066137182	0.37655544178979605
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.06589139999999999	0.375156069352156
GERODERMA OSTEODYSPLASTICUM; GO	0.06554878	0.3732053447889895
SAUL-WILSON SYNDROME; SWILS	0.06517516200000001	0.37107813152110913
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.06514098199999999	0.37088352593600293
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.06504453	0.3703343715212971
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.06487332999999999	0.36935963553036216
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.06484724	0.3692110907756689
HYPERTELORISM, TEEBI TYPE; TBHS	0.0636024	0.3621235303144807
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.063343882	0.36065164480686085
MECKEL SYNDROME, TYPE 6; MKS6	0.0626582	0.3567476791308314
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.0625	0.35584695930743243
EHLERS-DANLOS SYNDROME, TYPE I	0.0625	0.35584695930743243
EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5	0.0625	0.35584695930743243
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0625	0.35584695930743243
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0625	0.35584695930743243
ULNAR HYPOPLASIA	0.0625	0.35584695930743243
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0625	0.35584695930743243
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.0625	0.35584695930743243
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0625	0.35584695930743243
FEINGOLD SYNDROME 2; FGLDS2	0.0616601	0.3510649455294754
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.0616168	0.35081841475606723
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.061282500000000004	0.34891506054012367
FLYNN-AIRD SYNDROME	0.0606618	0.3453810732178497
ROSSELLI-GULIENETTI SYNDROME	0.060558681999999996	0.3447939655898518
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.060361812	0.3436730761357902
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0597148	0.33998928009042345
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0597148	0.33998928009042345
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.0597148	0.33998928009042345
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.059362729999999996	0.33798475146700957
WAARDENBURG SYNDROME, TYPE 1; WS1	0.058968	0.33573733594305083
OTOONYCHOPERONEAL SYNDROME	0.05887439999999999	0.335204419536792
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 5; EKVP5	0.0588236	0.3349151871282669
ACRORENAL SYNDROME	0.0588235	0.33491461777313203
WIDOW&#39;S PEAK SYNDROME	0.0588235	0.33491461777313203
Fabry disease	0.0588235	0.33491461777313203
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0588235	0.33491461777313203
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0588235	0.33491461777313203
ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	0.0588235	0.33491461777313203
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0588235	0.33491461777313203
HALLERMANN-STREIFF SYNDROME; HSS	0.0588235	0.33491461777313203
EPISODIC ATAXIA, TYPE 1; EA1	0.0588235	0.33491461777313203
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.0588235	0.33491461777313203
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0588235	0.33491461777313203
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.0588235	0.33491461777313203
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.0588235	0.33491461777313203
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0588235	0.33491461777313203
APROSENCEPHALY SYNDROME	0.0588235	0.33491461777313203
245800 LAURENCE-MOON SYNDROME	0.0588235	0.33491461777313203
DERMOCHONDROCORNEAL DYSTROPHY	0.0588235	0.33491461777313203
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.0586124	0.33371270908337525
ROIFMAN SYNDROME; RFMN	0.058572922	0.33348793906322266
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0583489	0.33221245830293517
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.05810013000000001	0.3307960735338646
DEAFNESS, MID-TONE NEURAL	0.05810013000000001	0.3307960735338646
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.0579537	0.32996236680984237
BLOOM SYNDROME	0.05775194	0.3288136358896845
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0566448	0.3225100774492424
ATKIN-FLAITZ SYNDROME	0.0566115	0.3223204821893234
CLARK-BARAITSER SYNDROME	0.0566115	0.3223204821893234
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.056399482	0.32111334681942827
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.056399482	0.32111334681942827
MEIER-GORLIN SYNDROME 1; MGORS1	0.05609604	0.3193856842110096
MEIER-GORLIN SYNDROME 6; MGORS6	0.055872870000000005	0.3181150543564714
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.055555600000000004	0.3163086613199999
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.055555600000000004	0.3163086613199999
NEMALINE MYOPATHY 2; NEM2	0.055555600000000004	0.3163086613199999
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.055555600000000004	0.3163086613199999
PEROXISOME BIOGENESIS DISORDER 14B	0.055555600000000004	0.3163086613199999
PERRAULT SYNDROME 4	0.055555600000000004	0.3163086613199999
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.055555600000000004	0.3163086613199999
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.055555600000000004	0.3163086613199999
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.055555600000000004	0.3163086613199999
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.055555600000000004	0.3163086613199999
#613453 DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91	0.055555600000000004	0.3163086613199999
STICKLER SYNDROME, TYPE II	0.055498830000000006	0.3159854384099218
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.055291162000000005	0.3148030699883945
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.0552188	0.314391073225684
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.0552188	0.314391073225684
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.0551515	0.31400789721990174
BLAU SYNDROME	0.054112499999999994	0.30809229736837496
OTOFACIOCERVICAL SYNDROME 2	0.053714899999999996	0.30582854135204485
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.053475482	0.30446540267518934
FIBROCHONDROGENESIS 1; FBCG1	0.05330274	0.30348188722807445
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.053233199999999994	0.30308595766727053
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.0532213	0.30301820440621846
15q26 overgrowth syndrome	0.05289503	0.3011605694076067
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.0527933	0.30058136442888117
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.05274398	0.3003005584763525
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.052719842	0.3001631275338923
FRONTONASAL DYSPLASIA 1; FND1	0.05270579	0.3000831217503373
THREE M SYNDROME 2; 3M2	0.0526316	0.299660717175761
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.052544530000000006	0.29916497965981065
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.0524867	0.2988357215853026
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0520482	0.2963390993188017
SMITH-MAGENIS SYNDROME; SMS	0.05124926199999999	0.29179030479119905
CHROMOSOME 10Q26 DELETION SYNDROME	0.051008092000000005	0.2904171910123804
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.050969182	0.2901956549293939
WHITE-SUTTON SYNDROME; WHSUS	0.050843882	0.28948225294537433
OROFACIODIGITAL SYNDROME IX; OFD9	0.050843882	0.28948225294537433
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.05079749	0.28921811771119527
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.05074373	0.2889120323906774
Rothmund-Thomson syndrome	0.0505747	0.2879496514061696
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.050439899999999996	0.28718216068433533
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.05	0.28467756744594597
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.05	0.28467756744594597
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.05	0.28467756744594597
HOLZGREVE SYNDROME	0.05	0.28467756744594597
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.05	0.28467756744594597
PERIPHERAL DYSOSTOSIS	0.05	0.28467756744594597
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.05	0.28467756744594597
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.05	0.28467756744594597
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.05	0.28467756744594597
#610265 DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	0.05	0.28467756744594597
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.05	0.28467756744594597
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.0499368	0.2843177350006943
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.0499108	0.2841697026656224
HYDROLETHALUS SYNDROME 1	0.0496952	0.2829421729947955
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.049091682	0.2795060122717986
COFFIN-SIRIS SYNDROME 5	0.049026811999999996	0.27913667159579425
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.048917792	0.2785159606277351
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.048690781999999995	0.277223467536017
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.048672112000000003	0.27711716893233274
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.048372500000000006	0.27541131262558044
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.04831613	0.27509036713604185
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.048279699999999995	0.27488295106040067
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0480781	0.27373513110845865
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.048026	0.27343849708318
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.047999030000000005	0.27328494200329967
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.04779721	0.27213586947006085
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.047651382	0.2713055902639507
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.047439300000000004	0.2700980905067693
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.047439300000000004	0.2700980905067693
#259450 BRUCK SYNDROME 1; BRKS1	0.047439300000000004	0.2700980905067693
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.047439300000000004	0.2700980905067693
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.047409599999999996	0.26992899203170634
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.047409599999999996	0.26992899203170634
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.046685962	0.2658089219206774
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.04664962	0.26560200687755503
BARTSOCAS-PAPAS SYNDROME; BPS	0.046543799999999996	0.2649995152738124
PRIMROSE SYNDROME; PRIMS	0.046516199999999994	0.26484237325658216
GENITOPATELLAR SYNDROME; GTPTS	0.046494282	0.2647175819981166
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.046175999999999995	0.26290542708768
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04564473	0.2598806140625398
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.0454545	0.258797529789435
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.0454545	0.258797529789435
PERRAULT SYNDROME 3	0.0454545	0.258797529789435
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IC	0.0454545	0.258797529789435
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0454545	0.258797529789435
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.0454545	0.258797529789435
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.0454545	0.258797529789435
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.0454545	0.258797529789435
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.0454545	0.258797529789435
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IIC	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IF	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IIA	0.0454545	0.258797529789435
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.0454545	0.258797529789435
USHER SYNDROME, TYPE IE; USH1E	0.0454545	0.258797529789435
DEAFNESS-OLIGODONTIA SYNDROME	0.0454545	0.258797529789435
DEAFNESS, X-LINKED 3	0.0454545	0.258797529789435
PENDRED SYNDROME	0.0454545	0.258797529789435
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.0454545	0.258797529789435
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0454545	0.258797529789435
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.0454545	0.258797529789435
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.045284982	0.257832370351869
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0451837	0.25725571608414777
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.0447958	0.2550471875159021
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.0445709	0.2537667078175302
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.0445633	0.2537234368272785
CORNEODERMATOOSSEOUS SYNDROME	0.0445633	0.2537234368272785
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.044445782	0.2530543420598562
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.044322182	0.25235061911312984
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.044232971999999995	0.2518426973972927
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.04421123	0.25171890820386456
CHROMOSOME 18Q DELETION SYNDROME	0.04414842	0.251361296243639
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.044108882	0.25113618461040543
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.043653482	0.24854334132610778
GOLDBERG-SHPRINTZEN SYNDROME	0.043646982	0.24850633324233978
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.043478300000000004	0.24754593361370147
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.043478300000000004	0.24754593361370147
THAUVIN-ROBINET-FAIVRE SYNDROME	0.043388412	0.24703415167004983
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.04304878	0.24510043943831378
KBG SYNDROME	0.042890281999999995	0.2441980229366128
BETHLEM MYOPATHY 1	0.042677400000000004	0.2429859683383523
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.042677400000000004	0.2429859683383523
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.042544530000000004	0.24222946617062144
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.04251058199999999	0.2420361814894283
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.04251058199999999	0.2420361814894283
RAINE SYNDROME	0.04251058199999999	0.2420361814894283
LAMB-SHAFFER SYNDROME	0.042354162	0.24114559618743045
CHROMOSOME 5Q12 DELETION SYNDROME	0.042354162	0.24114559618743045
GABRIELE-DE VRIES SYNDROME; GADEVS	0.042354162	0.24114559618743045
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0423512	0.24112873188833492
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.0423512	0.24112873188833492
CARTILAGE-HAIR HYPOPLASIA; CHH	0.042178499999999994	0.2401454555703766
SWEENEY-COX SYNDROME; SWCOS	0.042098682	0.2396910076888086
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.041874602	0.23841519670254285
INFANTILE LIVER FAILURE SYNDROME 1	0.041849912	0.23827462291973808
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0417293	0.23758791230444223
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.041666699999999994	0.23723149598999987
OTOSCLEROSIS 4	0.041666699999999994	0.23723149598999987
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.041666699999999994	0.23723149598999987
BRANCHIOOTORENAL SYNDROME 1	0.041666699999999994	0.23723149598999987
#612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATEMICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED	0.041666699999999994	0.23723149598999987
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.041666699999999994	0.23723149598999987
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.041602582	0.23686643686460992
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.041556380000000004	0.23660338340518722
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.041510280000000004	0.23634091068800203
SOTOS SYNDROME 2	0.041510280000000004	0.23634091068800203
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.041152782	0.23430547746786623
SPONDYLOOCULAR SYNDROME; SOS	0.041006030000000006	0.2334699374203097
%300712 CRANIOFACIOSKELETAL SYNDROME	0.040988722	0.23337139343356256
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0408086	0.2323458595774926
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.0407197	0.23183970286257372
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.040642002	0.23139732530986545
DEAFNESS, X-LINKED 2	0.04059579	0.23113421491492916
SPLIT-HAND/FOOT MALFORMATION 2	0.0405754	0.2310181234029247
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.040449662000000004	0.23030222764341438
Lipodystrophy, congenital generalized, type 2	0.04	0.22774205395675678
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.04	0.22774205395675678
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.04	0.22774205395675678
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.04	0.22774205395675678
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.04	0.22774205395675678
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.04	0.22774205395675678
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.04	0.22774205395675678
DERMATOLEUKODYSTROPHY	0.04	0.22774205395675678
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.04	0.22774205395675678
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.04	0.22774205395675678
Lipodystrophy, congenital generalized, type 1	0.04	0.22774205395675678
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.03995704	0.2274974589908072
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.039581530000000004	0.22535947352377467
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.039305382	0.2237872107058734
KAGAMI-OGATA SYNDROME	0.039305382	0.2237872107058734
CHROMOSOME 15q25 DELETION SYNDROME	0.039305382	0.2237872107058734
#300706 MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST;;MENTAL RETARDATION AND MACROCEPHALY SYNDROME	0.039075200000000004	0.22247665766927655
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.038677962	0.22021496271853472
THUMBS, CONGENITAL CLASPED	0.0384757	0.21906337363559966
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.03808326200000001	0.21682900773133265
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.037951912000000004	0.21608115976165213
#156550 KNIEST DYSPLASIA	0.03791719	0.21588346827171498
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.037880882	0.2156767468093384
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.037840372	0.21544610104419368
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.037811282	0.21528047563545366
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.037037	0.21087206130991
CRANIOSYNOSTOSIS 2	0.037037	0.21087206130991
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.037037	0.21087206130991
%190600 TRIPHALANGEAL THUMB, NONOPPOSABLE	0.037037	0.21087206130991
%174600 POLYDACTYLY, PREAXIAL III;;INDEX FINGER POLYDACTYLY	0.037037	0.21087206130991
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.037037	0.21087206130991
BIEMOND SYNDROME II	0.037037	0.21087206130991
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.037037	0.21087206130991
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	0.037037	0.21087206130991
#615550 DIAMOND-BLACKFAN ANEMIA 12; DBA12	0.037037	0.21087206130991
HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	0.037037	0.21087206130991
PREAXIAL HALLUCAL POLYDACTYLY	0.037037	0.21087206130991
FIBROSCLEROSIS, MULTIFOCAL	0.0369674	0.21047579013602524
BARDET-BIEDL SYNDROME 1; BBS1	0.036888062	0.2100240751591047
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.036843310000000004	0.20976927734913794
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0366868	0.2088781796275186
RETINITIS PIGMENTOSA 80; RP80	0.036558182	0.20814588644012338
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.036285562	0.2065937104713811
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.036150761999999996	0.2058262197495468
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.035975562	0.20482870955321622
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.03596563	0.20477216120121872
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.035646512	0.20295524648185442
WEYERS ACROFACIAL DYSOSTOSIS	0.03556164	0.20247202339176898
Helsmoortel-van der Aa syndrome	0.035034482000000006	0.1994706222497756
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.034866412	0.19851370707456278
KLEEFSTRA SYNDROME 2; KLEFS2	0.034355362	0.1956040176576978
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.034233981999999996	0.194912934394966
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.0341006	0.1941535171289445
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.0340433	0.19382727663665142
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0340433	0.19382727663665142
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.03379453	0.1924108918675809
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.03379453	0.1924108918675809
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.03379453	0.1924108918675809
CHROMOSOME 16p13.2 DELETION SYNDROME	0.033618932	0.1914111156378134
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	0.0334169	0.19026083607168864
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.033363452	0.18995652713919162
SPEECH-LANGUAGE DISORDER 1	0.03335178	0.18989007200784702
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.033182262000000004	0.18892491257028102
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.033101981999999995	0.18846783426798977
SCLEROSTEOSIS 2; SOST2	0.033096299999999995	0.18843548350922518
HURLER SYNDROME	0.033048982	0.18816607604649704
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.033048982	0.18816607604649704
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.032980512000000003	0.18777623858563663
SHUKLA-VERNON SYNDROME; SHUVER	0.032890062000000005	0.1872612568661269
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.032869682	0.1871452222896359
WAARDENBURG SYNDROME, TYPE IIB	0.03284753	0.18701909874015465
HUNTER-MACDONALD SYNDROME	0.032800159999999995	0.18674939521275635
#615328 SHAHEEN SYNDROME; SHNS	0.032460579999999996	0.18481597904569047
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.0323929	0.18443063949039568
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.0323929	0.18443063949039568
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0323929	0.18443063949039568
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.0323929	0.18443063949039568
SPINOCEREBELLAR ATAXIA 47; SCA47	0.03233838	0.1841202270708526
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0322581	0.18366314876856138
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.0322581	0.18366314876856138
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.0322581	0.18366314876856138
AICARDI SYNDROME; AIC	0.0322581	0.18366314876856138
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.0322581	0.18366314876856138
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0322581	0.18366314876856138
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.0322581	0.18366314876856138
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0322581	0.18366314876856138
RADIAL-RENAL SYNDROME	0.0322581	0.18366314876856138
COWDEN SYNDROME 5; CWS5	0.0322051	0.18336139054706868
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.0322051	0.18336139054706868
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.0322051	0.18336139054706868
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0322051	0.18336139054706868
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.0322051	0.18336139054706868
COWDEN SYNDROME 6; CWS6	0.0322051	0.18336139054706868
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.03195633	0.1819450057779981
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.031830862	0.18123064727735197
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.031306582	0.17824563217614076
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.03125	0.17792347965371622
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL DOMINANT 70	0.03125	0.17792347965371622
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.03125	0.17792347965371622
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.03125	0.17792347965371622
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.03125	0.17792347965371622
USHER SYNDROME, TYPE IV; USH4	0.03125	0.17792347965371622
#613285 DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25	0.03125	0.17792347965371622
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.03125	0.17792347965371622
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03125	0.17792347965371622
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.03125	0.17792347965371622
CINCA SYNDROME; CINCA	0.03125	0.17792347965371622
#615540 DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76	0.03125	0.17792347965371622
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.03119683	0.17762075352849419
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031146881999999997	0.1773363720257184
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.031146881999999997	0.1773363720257184
SEPTOOPTIC DYSPLASIA	0.031146881999999997	0.1773363720257184
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.031039112	0.1767227779968454
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.031039112	0.1767227779968454
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.030916100000000002	0.17602240285831222
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.03084	0.17558912360065945
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0307549	0.17510460238086648
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0307018	0.17480227480423888
#256520 NEU-LAXOVA SYNDROME; NLS	0.0307018	0.17480227480423888
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.03046573	0.1734581981372996
22q11.2 distal deletion syndrome	0.030302999999999997	0.17253168652629
EAR WAX, WET/DRY	0.030302999999999997	0.17253168652629
METATROPIC DYSPLASIA	0.030302999999999997	0.17253168652629
MUSICAL PERFECT PITCH	0.030302999999999997	0.17253168652629
NASAL BONES, ABSENCE OF	0.030302999999999997	0.17253168652629
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	0.17253168652629
AREDYLD	0.030302999999999997	0.17253168652629
EAR FOLDING	0.030302999999999997	0.17253168652629
CYANIDE, INABILITY TO SMELL	0.030302999999999997	0.17253168652629
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.030302999999999997	0.17253168652629
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.030302999999999997	0.17253168652629
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	0.17253168652629
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.030302999999999997	0.17253168652629
DARWINIAN POINT OF PINNA	0.030302999999999997	0.17253168652629
DIMPLES, FACIAL	0.030302999999999997	0.17253168652629
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	0.17253168652629
DWARFISM, LEVI TYPE	0.030302999999999997	0.17253168652629
MENKES DISEASE	0.030302999999999997	0.17253168652629
15q24 recurrent microdeletion syndrome	0.030302999999999997	0.17253168652629
CLEFT CHIN	0.030302999999999997	0.17253168652629
OROFACIAL CLEFT 3	0.030302999999999997	0.17253168652629
15q13.3 microdeletion syndrome	0.030302999999999997	0.17253168652629
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.030302999999999997	0.17253168652629
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	0.17253168652629
EAR WITHOUT HELIX	0.030302999999999997	0.17253168652629
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	0.17253168652629
OSSIFIED EAR CARTILAGES	0.030302999999999997	0.17253168652629
EAR ANTITRAGUS, TAG AT BASE OF	0.030302999999999997	0.17253168652629
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.030302999999999997	0.17253168652629
ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	0.030302999999999997	0.17253168652629
HAIRY EARS, Y-LINKED	0.030302999999999997	0.17253168652629
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	0.17253168652629
FRYNS MICROPHTHALMIA SYNDROME	0.030302999999999997	0.17253168652629
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.030302999999999997	0.17253168652629
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.030302999999999997	0.17253168652629
DARWINIAN TUBERCLE OF PINNA	0.030302999999999997	0.17253168652629
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	0.17253168652629
Growth hormone deficiency, isolated, type IA	0.030302999999999997	0.17253168652629
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	0.17253168652629
OSTEOMA OF MIDDLE EAR	0.030302999999999997	0.17253168652629
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.030302999999999997	0.17253168652629
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	0.17253168652629
ALKAPTONURIA	0.030302999999999997	0.17253168652629
EAR MALFORMATION	0.030302999999999997	0.17253168652629
#192500 LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVALLONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	0.030302999999999997	0.17253168652629
EXCHONDROSIS OF PINNA, POSTERIOR	0.030302999999999997	0.17253168652629
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	0.17253168652629
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.030302999999999997	0.17253168652629
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.030302999999999997	0.17253168652629
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	0.17253168652629
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	0.17253168652629
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.030302999999999997	0.17253168652629
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.030255682	0.17226227906356187
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.030255682	0.17226227906356187
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.03024848	0.17222127410674695
MECKEL SYNDROME, TYPE 1; MKS1	0.030202100000000003	0.1719572071951841
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.029826402	0.16981815134049794
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.029723162000000004	0.16923034909923557
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.029704212	0.16912245630117353
Retinitis pigmentosa with or without skeletal anomalies	0.029460862	0.16773693058041414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.029454362	0.16769992249664617
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.0294118	0.16745759356413345
HAIR WHORL	0.0294118	0.16745759356413345
PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	0.0294118	0.16745759356413345
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.0294118	0.16745759356413345
MIDPHALANGEAL HAIR	0.0294118	0.16745759356413345
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	0.0294118	0.16745759356413345
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	0.0294118	0.16745759356413345
PAPILLON-LEFEVRE SYNDROME	0.0294118	0.16745759356413345
RINGED HAIR	0.0294118	0.16745759356413345
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.0294118	0.16745759356413345
WEILL-MARCHESANI SYNDROME 3	0.0294118	0.16745759356413345
#226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;;EBS-MD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS	0.0294118	0.16745759356413345
ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS	0.0294118	0.16745759356413345
PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC	0.0294118	0.16745759356413345
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0294118	0.16745759356413345
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0294118	0.16745759356413345
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.0294118	0.16745759356413345
%152800 LYMPHANGIECTASIA, INTESTINAL	0.0294118	0.16745759356413345
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0294118	0.16745759356413345
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.0294118	0.16745759356413345
EPIDERMOLYTIC HYPERKERATOSIS	0.0294118	0.16745759356413345
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0294118	0.16745759356413345
PACHYONYCHIA CONGENITA, TYPE 1	0.0294118	0.16745759356413345
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.0294118	0.16745759356413345
EPIDERMOLYSIS BULLOSA SIMPLEX, KOEBNER TYPE	0.0294118	0.16745759356413345
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13	0.0294118	0.16745759356413345
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.0294118	0.16745759356413345
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.0294118	0.16745759356413345
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4; EKVP4	0.0294118	0.16745759356413345
CATATRICHY	0.0294118	0.16745759356413345
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0294118	0.16745759356413345
TRICHODENTOOSSEOUS SYNDROME	0.0294118	0.16745759356413345
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.0294118	0.16745759356413345
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0294118	0.16745759356413345
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.0294118	0.16745759356413345
SYNDESMODYSPLASIC DWARFISM	0.0294118	0.16745759356413345
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.0294118	0.16745759356413345
WERNER SYNDROME; WRN	0.0294118	0.16745759356413345
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.0294118	0.16745759356413345
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0294118	0.16745759356413345
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0294118	0.16745759356413345
611426 TENTED EYEBROWS	0.0294118	0.16745759356413345
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.0294118	0.16745759356413345
PFEIFFER-PALM-TELLER SYNDROME	0.0294118	0.16745759356413345
#609165 ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE;;ICHTHYOSIS WITH CONFETTI; IWC;;ICHTHYOSIS VARIEGATAERYTHROKERATODERMA, RETICULAR, INCLUDED;;AARAU DISEASE, INCLUDED	0.0294118	0.16745759356413345
KINDLER SYNDROME; KNDLRS	0.0294118	0.16745759356413345
HAIRY NOSE TIP	0.0294118	0.16745759356413345
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.0294118	0.16745759356413345
MANITOBA OCULOTRICHOANAL SYNDROME	0.0294118	0.16745759356413345
HURLER-SCHEIE SYNDROME	0.0294118	0.16745759356413345
BUSCHKE-OLLENDORFF SYNDROME; BOS	0.0294118	0.16745759356413345
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.0294118	0.16745759356413345
MYOPATHY, DISTAL 3	0.0290309	0.16528891985533023
#603543 LIMB-MAMMARY SYNDROME; LMS	0.0290309	0.16528891985533023
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0290309	0.16528891985533023
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0290309	0.16528891985533023
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.028950112000000004	0.1648289492289538
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.028906212000000004	0.16457900232473627
Mental retardation, autosomal dominant 21	0.028782082000000004	0.16387226179579495
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.02861048	0.16289523699721775
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.028595062	0.16280745382252013
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.028593802	0.16280027994782048
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0285714	0.162672733010502
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0285714	0.162672733010502
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.0285714	0.162672733010502
PROTRUSIO ACETABULI	0.0285714	0.162672733010502
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.0285714	0.162672733010502
MYOPATHY, CENTRONUCLEAR, 5	0.0285714	0.162672733010502
MCDONOUGH SYNDROME	0.0285329	0.16245353128356863
HYPOMELIA WITH MULLERIAN DUCT ANOMALIES	0.0285312	0.16244385224627547
ECTRODACTYLY-POLYDACTYLY	0.0285312	0.16244385224627547
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.02821369	0.16063609275748023
CHROMOSOME 16p13.3 DELETION SYNDROME	0.028203622	0.16057877008249932
CHROMOSOME 2q37 DELETION SYNDROME	0.028090812	0.15993648055482776
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.028089552	0.1599293066801281
PITT-HOPKINS SYNDROME	0.028062330000000003	0.15977431682530788
MARDEN-WALKER SYNDROME	0.0276507	0.15743068028355237
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.027527589999999998	0.15672974717698693
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.027495699999999998	0.15654817982446992
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.027446682	0.1562690933244486
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.027365900000000002	0.15580915685938027
HYPEREKPLEXIA 4; HKPX4	0.027159682	0.15463504408730888
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.027159682	0.15463504408730888
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.027159682	0.15463504408730888
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.027159682	0.15463504408730888
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.027159682	0.15463504408730888
PTERYGIUM, ANTECUBITAL	0.027027	0.15387961230723163
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.027027	0.15387961230723163
#602111 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE;;SEMD, MISSOURI TYPEMETAPHYSEAL ANADYSPLASIA 1, INCLUDED; MANDP1, INCLUDED	0.027027	0.15387961230723163
#608728 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED;;SEMD, MATN3-RELATED	0.027027	0.15387961230723163
PYLE DISEASE; PYL	0.027027	0.15387961230723163
RADIOULNAR SYNOSTOSIS	0.027027	0.15387961230723163
HYPOCHONDROPLASIA	0.027027	0.15387961230723163
RADIAL HEADS, POSTERIOR DISLOCATION OF	0.027027	0.15387961230723163
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.026405582000000004	0.15034153701508915
STICKLER SYNDROME, TYPE I	0.02638312	0.1502136484646897
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0263158	0.1498303585878805
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0263158	0.1498303585878805
MASA SYNDROME	0.0263158	0.1498303585878805
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0263158	0.1498303585878805
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0263158	0.1498303585878805
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.026140499999999997	0.148832279036415
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.026049982000000003	0.1483169101554136
POPOV-CHANG SYNDROME; POPCHAS	0.025837222	0.14710555017041757
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.025669152	0.14614863499520478
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.025545022	0.14544189446626346
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.025545022	0.14544189446626346
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.025362742	0.14440407392638252
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.02531531	0.1441340173988006
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.025201110000000002	0.1434838138347541
SMITH-MCCORT DYSPLASIA 2; SMC2	0.0247024	0.1406443828415347
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.0247024	0.1406443828415347
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.0247024	0.1406443828415347
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.0247024	0.1406443828415347
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0247024	0.1406443828415347
MACDERMOT-WINTER SYNDROME	0.024653382	0.1403652963415134
RECOMBINANT CHROMOSOME 8 SYNDROME	0.024547022	0.1397597302200424
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0245025	0.13950624192688582
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0241469	0.13748161506721024
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.023927362	0.1362316641911713
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0238095	0.135560610842085
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.0238095	0.135560610842085
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.0238095	0.135560610842085
MESOMELIC LIMB SHORTENING AND BOWING	0.0238095	0.135560610842085
2p15-16.1 microdeletion syndrome	0.0238095	0.135560610842085
CAMPTODACTYLY 1; CAMPD1	0.0238095	0.135560610842085
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0238095	0.135560610842085
SPONDYLOCAMPTODACTYLY	0.0238095	0.135560610842085
BARATELA-SCOTT SYNDROME	0.023655152000000002	0.13468182257848207
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.023635162	0.13456800848701717
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.023631489999999998	0.13454710176646392
TONNE-KALSCHEUER SYNDROME; TOKAS	0.023500462000000003	0.13380108712031782
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.023500462000000003	0.13380108712031782
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.023500462000000003	0.13380108712031782
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.023244982000000004	0.132346498621696
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.023155112	0.13183481916196865
SHORT SYNDROME	0.023137210000000002	0.13173289320572032
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.023110412	0.13158031741667198
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.023110412	0.13158031741667198
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.023110412	0.13158031741667198
BASAN SYNDROME	0.0230372	0.13116348113531492
RAYNAUD-CLAES SYNDROME; MRXSRC	0.022818212	0.12991666171251787
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.022818212	0.12991666171251787
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.022818212	0.12991666171251787
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.022818212	0.12991666171251787
DESANTO-SHINAWI SYNDROME	0.022743991999999998	0.12949408633140108
OCULOSKELETODENTAL SYNDROME; OCSKD	0.022505082000000003	0.1281338399786309
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.02250369	0.12812591455515318
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0224011	0.1275418131222676
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02215233	0.12612542835319707
LATHOSTEROLOSIS	0.02200399	0.12528084694609842
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.02191668	0.12478374297782431
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.021818982	0.12422749439813761
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0216612	0.12332915447920247
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0216612	0.12332915447920247
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.02141243	0.12191276971013193
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.02141243	0.12191276971013193
JOHANSON-BLIZZARD SYNDROME; JBS	0.02128547	0.12118991643087319
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.02126544	0.12107587459735433
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.021020511999999998	0.11968136445256632
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.021020511999999998	0.11968136445256632
HYPERPROLINEMIA, TYPE I	0.020841862000000003	0.11866421150408196
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.020841862000000003	0.11866421150408196
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.020841862000000003	0.11866421150408196
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.020841862000000003	0.11866421150408196
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.020841862000000003	0.11866421150408196
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.020841862000000003	0.11866421150408196
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.020841862000000003	0.11866421150408196
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.020841862000000003	0.11866421150408196
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.020841862000000003	0.11866421150408196
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.020710512	0.11791636353440146
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.020644022	0.11753779930521184
BAND HETEROTOPIA; BH	0.020451682000000002	0.11644270163876079
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020451682000000002	0.11644270163876079
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020451682000000002	0.11644270163876079
MENTAL RETARDATION, X-LINKED 99	0.020451682000000002	0.11644270163876079
OROFACIODIGITAL SYNDROME I; OFD1	0.0203372	0.11579089249323385
TEMPLE SYNDROME	0.02029018	0.11552318170880767
COFFIN-SIRIS SYNDROME 7; CSS7	0.020199462	0.11500667411753646
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.02008843	0.11437450772416329
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.02008843	0.11437450772416329
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.02008843	0.11437450772416329
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.019711782	0.11223004299569567
TOE, MISSHAPEN	0.0196078	0.1116380161393324
HHHH SYNDROME	0.0196078	0.1116380161393324
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.1116380161393324
KNUCKLE PADS	0.0196078	0.1116380161393324
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.1116380161393324
#215300 CHONDROSARCOMA	0.0196078	0.1116380161393324
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	0.1116380161393324
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.1116380161393324
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0196078	0.1116380161393324
MONOPHALANGY OF GREAT TOE	0.0196078	0.1116380161393324
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	0.1116380161393324
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.0196078	0.1116380161393324
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.1116380161393324
VESICOURETERAL REFLUX 1	0.0196078	0.1116380161393324
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.1116380161393324
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.1116380161393324
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.1116380161393324
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	0.1116380161393324
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.1116380161393324
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.1116380161393324
RAYNAUD DISEASE	0.0196078	0.1116380161393324
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.1116380161393324
VAN DEN BOSCH SYNDROME	0.0196078	0.1116380161393324
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.1116380161393324
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.1116380161393324
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	0.1116380161393324
PUBIC BONE DYSPLASIA	0.0196078	0.1116380161393324
THROMBOCYTOPENIA 3	0.0196078	0.1116380161393324
NEPHROSIALIDOSIS	0.0196078	0.1116380161393324
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.1116380161393324
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	0.1116380161393324
MEGAEPIPHYSEAL DWARFISM	0.0196078	0.1116380161393324
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.1116380161393324
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	0.1116380161393324
MICROCEPHALY, AUTOSOMAL DOMINANT	0.0196078	0.1116380161393324
CARPAL DISPLACEMENT	0.0196078	0.1116380161393324
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.1116380161393324
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.1116380161393324
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	0.1116380161393324
SPINAL ARACHNOIDITIS	0.0196078	0.1116380161393324
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.1116380161393324
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	0.1116380161393324
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	0.1116380161393324
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.1116380161393324
LETTERER-SIWE DISEASE	0.0196078	0.1116380161393324
TRACHEOBRONCHOMEGALY	0.0196078	0.1116380161393324
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.019584822	0.11150718971643693
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.01951793	0.11112633667960503
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.019510182	0.11108222304375362
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.019382512	0.11035532734303714
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.019382512	0.11035532734303714
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.019025682	0.10832369741520238
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019025682	0.10832369741520238
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.019012522	0.10824877027945062
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0188679	0.10742535749626728
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.10742535749626728
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.10742535749626728
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	0.10742535749626728
MOTION SICKNESS	0.0188679	0.10742535749626728
CERVICAL RIB	0.0188679	0.10742535749626728
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.10742535749626728
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.10742535749626728
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	0.10742535749626728
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.10742535749626728
#181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2;;EMD2;;EMERY-DREIFUSS MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT;;SCAPULOILIOPERONEAL ATROPHY WITH CARDIOPATHY;;MUSCULAR DYSTROPHY WITH EARLY CONTRACTURES AND CARDIOMYOPATHY, AUTOSOMALDOMINANT;;HAUPTMANN-THANNHAUSER MUSCULAR DYSTROPHYEMERY-DREIFUSS MUSCULAR DYSTROPHY, ATYPICAL, AUTOSOMAL RECESSIVE,INCLUDED;;EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE, INCLUDED;EDMD3, INCLUDED	0.0188679	0.10742535749626728
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.10742535749626728
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.10742535749626728
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.10742535749626728
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.0188679	0.10742535749626728
RHEUMATOID ARTHRITIS	0.0188679	0.10742535749626728
PALMOMENTAL REFLEX	0.0188679	0.10742535749626728
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.10742535749626728
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.10742535749626728
ALCOHOL DEPENDENCE	0.0188679	0.10742535749626728
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0188679	0.10742535749626728
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.10742535749626728
MYOPATHY, CONGENITAL	0.0188679	0.10742535749626728
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.10742535749626728
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.10742535749626728
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.10742535749626728
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.10742535749626728
ERYTHERMALGIA, PRIMARY	0.0188679	0.10742535749626728
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.0188679	0.10742535749626728
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	0.10742535749626728
BRUCK SYNDROME 2	0.0188679	0.10742535749626728
269800 SENILE PLAQUE FORMATION	0.0188679	0.10742535749626728
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	0.10742535749626728
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.10742535749626728
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.10742535749626728
JUMPING FRENCHMAN OF MAINE	0.0188679	0.10742535749626728
CARDIAC ARRHYTHMIA	0.0188679	0.10742535749626728
RUIJS-AALFS SYNDROME; RJALS	0.0188679	0.10742535749626728
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.10742535749626728
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.10742535749626728
TRANSSEXUALITY	0.0188679	0.10742535749626728
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.10742535749626728
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.10742535749626728
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.10742535749626728
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	0.10742535749626728
#615325 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R	0.0188679	0.10742535749626728
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.10742535749626728
DIASTEMATOMYELIA	0.0188679	0.10742535749626728
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.10742535749626728
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	0.10742535749626728
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.10742535749626728
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.10742535749626728
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.0188679	0.10742535749626728
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.018788682	0.10697432574550862
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.018788682	0.10697432574550862
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.01874094	0.10670250421700854
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.018666299999999997	0.1062775375443252
MUCOPOLYSACCHARIDOSIS, TYPE II	0.018666299999999997	0.1062775375443252
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.018527212	0.1054856328743068
JOUBERT SYNDROME 24	0.018527212	0.1054856328743068
Split hand/foot malformation 1 (SHFM1)	0.018417529999999998	0.10486115277525464
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.018417529999999998	0.10486115277525464
#118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	0.018417529999999998	0.10486115277525464
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.018417529999999998	0.10486115277525464
CHROMOSOME 18P DELETION SYNDROME	0.018387782000000002	0.10469178100972704
GLASS SYNDROME	0.018385462	0.10467857197059753
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.018385462	0.10467857197059753
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.018385462	0.10467857197059753
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.018181799999999998	0.10351901191577399
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.018181799999999998	0.10351901191577399
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.018181799999999998	0.10351901191577399
THUMB DEFORMITY AND ALOPECIA	0.018181799999999998	0.10351901191577399
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.018181799999999998	0.10351901191577399
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.018085282	0.10296948172667905
ZTTK SYNDROME; ZTTKS	0.018085282	0.10296948172667905
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.017944799999999997	0.1021696402460802
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.017793082	0.10130582602252494
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.017793082	0.10130582602252494
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.017793082	0.10130582602252494
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.017793082	0.10130582602252494
MENTAL RETARDATION, X-LINKED 107; MRX107	0.017793082	0.10130582602252494
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.017793082	0.10130582602252494
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.017793082	0.10130582602252494
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0175439	0.09988709551029863
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.0175439	0.09988709551029863
109300 BANKI SYNDROME	0.0175439	0.09988709551029863
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.0175439	0.09988709551029863
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0175439	0.09988709551029863
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.0175439	0.09988709551029863
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.0175439	0.09988709551029863
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.017406162	0.09910287713460124
XQ25 DUPLICATION SYNDROME	0.017406162	0.09910287713460124
AYME-GRIPP SYNDROME; AYGRP	0.017386030000000004	0.09898825455884482
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.01733448	0.09869475198680802
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.0172414	0.09816479622725065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0172414	0.09816479622725065
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.0172414	0.09816479622725065
SCHOLTE SYNDROME; SHLTS	0.0172414	0.09816479622725065
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.0172414	0.09816479622725065
CHOPS SYNDROME; CHOPS	0.017150682	0.09764828863597942
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.01709773	0.09734680370495147
RETT SYNDROME; RTT	0.0169492	0.09650114052309655
MENTAL RETARDATION, X-LINKED 82	0.0169492	0.09650114052309655
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.0169492	0.09650114052309655
46,XY SEX REVERSAL 9; SRXY9	0.0169492	0.09650114052309655
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.0169492	0.09650114052309655
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.0169492	0.09650114052309655
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.016901912	0.09623190386690887
KLEEFSTRA SYNDROME	0.016831079999999998	0.09582861823776223
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.016716882	0.09517842606081839
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.016716882	0.09517842606081839
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.016716882	0.09517842606081839
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.01656228	0.09429819163517283
TENORIO SYNDROME; TNORS	0.01656228	0.09429819163517283
COFFIN-SIRIS SYNDROME 8; CSS8	0.01656228	0.09429819163517283
JOUBERT SYNDROME 30; JBTS30	0.016550862000000003	0.0942331826658709
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.0163068	0.09284360313655103
DEAFNESS, X-LINKED 7; DFNX7	0.0163068	0.09284360313655103
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.016295382000000004	0.0927785941672491
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01605803	0.09142721836748048
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.015995382	0.09107052876257339
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.015995382	0.09107052876257339
ADAMS-OLIVER SYNDROME 3; AOS3	0.015995382	0.09107052876257339
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.015940862000000004	0.09076011634303036
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.015940862	0.09076011634303034
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.015872999999999998	0.09037374056139
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.015872999999999998	0.09037374056139
#614455 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE;;CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS	0.015872999999999998	0.09037374056139
#607706 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE;;CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A, AXONAL FORM;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE	0.015872999999999998	0.09037374056139
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.015872999999999998	0.09037374056139
#612576 CHROMOSOME 17P13.3, TELOMERIC, DUPLICATION SYNDROME;;SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 3; SHFLD3	0.015872999999999998	0.09037374056139
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.015872999999999998	0.09037374056139
#605726 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE;;NEUROPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE; HMNJ;;SPINAL MUSCULAR ATROPHY, JERASH TYPE	0.015872999999999998	0.09037374056139
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.015872999999999998	0.09037374056139
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.015872999999999998	0.09037374056139
SPLIT-HAND AND SPLIT-FOOT WITH HYPODONTIA	0.015872999999999998	0.09037374056139
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.015872999999999998	0.09037374056139
BARDET-BIEDL SYNDROME 21; BBS21	0.015706980000000002	0.0894284971664425
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.01570243	0.0894025915078049
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.015336682	0.08732018648904051
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.015336682	0.08732018648904051
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.015151499999999998	0.086265843263145
HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS	0.015151499999999998	0.086265843263145
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.015151499999999998	0.086265843263145
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	0.015151499999999998	0.086265843263145
ZECHI-CEIDE SYNDROME	0.015151499999999998	0.086265843263145
OPSISMODYSPLASIA; OPSMD	0.015151499999999998	0.086265843263145
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.015151499999999998	0.086265843263145
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.015151499999999998	0.086265843263145
ALAGILLE SYNDROME 1; ALGS1	0.015151499999999998	0.086265843263145
CURVED NAIL OF FOURTH TOE	0.015151499999999998	0.086265843263145
241519 HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS	0.015151499999999998	0.086265843263145
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.015151499999999998	0.086265843263145
SPASTIC PARAPLEGIA 16, X-LINKED	0.015151499999999998	0.086265843263145
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.015096980000000003	0.08595543084360195
SIFRIM-HITZ-WEISS SYNDROME	0.014841500000000002	0.08450084234498015
WARSAW BREAKAGE SYNDROME; WABS	0.014626182000000001	0.08327491825563361
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0144928	0.0825155009896121
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.0144928	0.0825155009896121
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.0144928	0.0825155009896121
ACHARD SYNDROME	0.0144928	0.0825155009896121
#614416 RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES;RHFCA	0.0144928	0.0825155009896121
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.0144928	0.0825155009896121
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.0144928	0.0825155009896121
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.0144928	0.0825155009896121
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0144928	0.0825155009896121
LOEYS-DIETZ SYNDROME 5	0.0144928	0.0825155009896121
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.0144928	0.0825155009896121
ARTERIAL TORTUOSITY SYNDROME	0.0144928	0.0825155009896121
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0144928	0.0825155009896121
601095 HARROD SYNDROME	0.0144928	0.0825155009896121
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0144928	0.0825155009896121
MARFAN SYNDROME; MFS	0.0144928	0.0825155009896121
MARFANOID HYPERMOBILITY SYNDROME	0.0144928	0.0825155009896121
LOEYS-DIETZ SYNDROME 3; LDS3	0.0144928	0.0825155009896121
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0144928	0.0825155009896121
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.0144928	0.0825155009896121
PEROXISOME BIOGENESIS DISORDER 3B	0.014377412000000001	0.08185853348656306
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.014377412000000001	0.08185853348656306
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.014357382	0.0817444916530442
HOLOPROSENCEPHALY 11	0.014357382	0.0817444916530442
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.014357382	0.0817444916530442
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.014357382	0.0817444916530442
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.014357382	0.0817444916530442
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.014357382	0.0817444916530442
ALAZAMI-YUAN SYNDROME	0.014357382	0.0817444916530442
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.014309362000000003	0.08147108731726914
THIEMANN DISEASE	0.0142857	0.081336366505251
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0142857	0.081336366505251
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.0142857	0.081336366505251
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.0142857	0.081336366505251
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0142857	0.081336366505251
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.0142857	0.081336366505251
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.0142857	0.081336366505251
FRANK-TER HAAR SYNDROME; FTHS	0.0142857	0.081336366505251
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.014189132	0.08078655163858861
#602398 DESMOSTEROLOSIS	0.014001782	0.07971986479336865
611961 STEVENSON-CAREY SYNDROME	0.014001782	0.07971986479336865
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.013620952	0.07755158963315985
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0135135	0.07693980615361581
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0135135	0.07693980615361581
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.0135135	0.07693980615361581
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0135135	0.07693980615361581
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.0135135	0.07693980615361581
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0135135	0.07693980615361581
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.0135135	0.07693980615361581
OROFACIODIGITAL SYNDROME XVI; OFD16	0.013502082000000002	0.07687479718431386
JOUBERT SYNDROME 7	0.013502082000000002	0.07687479718431386
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.013502082000000002	0.07687479718431386
JOUBERT SYNDROME 1	0.013502082000000002	0.07687479718431386
COACH SYNDROME	0.013502082000000002	0.07687479718431386
Bardet-Biedl syndrome 2	0.013502082000000002	0.07687479718431386
#615665 JOUBERT SYNDROME 22; JBTS22	0.013502082000000002	0.07687479718431386
JOUBERT SYNDROME 2	0.013502082000000002	0.07687479718431386
ARIMA SYNDROME	0.013502082000000002	0.07687479718431386
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.013502082000000002	0.07687479718431386
ABLEPHARON-MACROSTOMIA SYNDROME	0.013465480000000002	0.07666640181784073
COFFIN-SIRIS SYNDROME 6; CSS6	0.013238452	0.07537380624219836
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.013210000000000001	0.07521181331921892
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.0131579	0.07491517929394025
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.0131579	0.07491517929394025
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0131579	0.07491517929394025
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.0131579	0.07491517929394025
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0131579	0.07491517929394025
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.0131579	0.07491517929394025
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0131579	0.07491517929394025
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0131579	0.07491517929394025
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0131579	0.07491517929394025
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.0131579	0.07491517929394025
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.012892082000000003	0.07340173086147332
CEREBELLOFACIODENTAL SYNDROME	0.012892082000000003	0.07340173086147332
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.012892082000000003	0.07340173086147332
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012892082000000003	0.07340173086147332
PEHO SYNDROME; PEHO	0.012892082000000003	0.07340173086147332
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.012892082000000003	0.07340173086147332
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.012892082000000003	0.07340173086147332
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.012892082000000003	0.07340173086147332
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.012892082000000003	0.07340173086147332
IMMUNODEFICIENCY 23; IMD23	0.012734202	0.07250283297450599
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.012734202	0.07250283297450599
PSEUDOTRISOMY 13 SYNDROME	0.012658200000000001	0.07207011168488547
MECKEL SYNDROME, TYPE 5	0.012658200000000001	0.07207011168488547
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.012658200000000001	0.07207011168488547
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.012658200000000001	0.07207011168488547
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.012658200000000001	0.07207011168488547
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.012658200000000001	0.07207011168488547
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.012658200000000001	0.07207011168488547
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.012658200000000001	0.07207011168488547
MECKEL SYNDROME, TYPE 4; MKS4	0.012658200000000001	0.07207011168488547
POLYDACTYLY, POSTAXIAL, TYPE A2	0.012658200000000001	0.07207011168488547
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.012658200000000001	0.07207011168488547
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.012658200000000001	0.07207011168488547
ULNAR-MAMMARY SYNDROME; UMS	0.012658200000000001	0.07207011168488547
POLYDACTYLY, POSTAXIAL, TYPE A9; PAPA9	0.012658200000000001	0.07207011168488547
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.012658200000000001	0.07207011168488547
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.012658200000000001	0.07207011168488547
OROFACIODIGITAL SYNDROME V; OFD5	0.012658200000000001	0.07207011168488547
OROFACIODIGITAL SYNDROME III	0.012658200000000001	0.07207011168488547
OLIVER SYNDROME	0.012658200000000001	0.07207011168488547
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.012658200000000001	0.07207011168488547
CEREBROOCULONASAL SYNDROME	0.012658200000000001	0.07207011168488547
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.01213909	0.06911453224414817
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.012048200000000002	0.06859704536204493
HURIEZ SYNDROME; HRZ	0.012048200000000002	0.06859704536204493
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.01189032	0.0676981474750776
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.01189032	0.0676981474750776
HEMIFACIAL MICROSOMIA	0.01189032	0.0676981474750776
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.011832882000000001	0.0673711212726984
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.011832882000000001	0.0673711212726984
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.011832882000000001	0.0673711212726984
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.011832882000000001	0.0673711212726984
ADAMS-OLIVER SYNDROME 2; AOS2	0.011832882000000001	0.0673711212726984
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.011832882000000001	0.0673711212726984
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.011644602	0.06629913942472394
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.011644602	0.06629913942472394
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.011260582000000002	0.0641127018357121
MARINESCO-SJOGREN SYNDROME; MSS	0.011260582000000002	0.0641127018357121
ROIFMAN-CHITAYAT SYNDROME	0.011260582000000002	0.0641127018357121
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.011140352	0.06342816615703158
POTOCKI-SHAFFER SYNDROME	0.010989	0.06256643577327001
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.010989	0.06256643577327001
OROFACIAL CLEFT 15	0.010989	0.06256643577327001
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.010989	0.06256643577327001
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.010989	0.06256643577327001
MACS SYNDROME	0.010989	0.06256643577327001
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.01080072	0.06149445392529554
DUBOWITZ SYNDROME	0.01080072	0.06149445392529554
OHDO SYNDROME	0.01054524	0.06003986542667375
ATELOSTEOGENESIS, TYPE I; AO1	0.010416700000000001	0.05930801633628371
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.010416700000000001	0.05930801633628371
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.010416700000000001	0.05930801633628371
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.010416700000000001	0.05930801633628371
CZECH DYSPLASIA, METATARSAL TYPE	0.010416700000000001	0.05930801633628371
EXOSTOSES, MULTIPLE, TYPE I	0.010416700000000001	0.05930801633628371
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.010416700000000001	0.05930801633628371
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.010416700000000001	0.05930801633628371
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.010416700000000001	0.05930801633628371
EXOSTOSES, MULTIPLE, TYPE II	0.010416700000000001	0.05930801633628371
BRACHYDACTYLY, TYPE E	0.010416700000000001	0.05930801633628371
BRACHYDACTYLY, TYPE E2; BDE2	0.010416700000000001	0.05930801633628371
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.010416700000000001	0.05930801633628371
WILLIAMS-BEUREN SYNDROME; WBS	0.01029647	0.05862348065760318
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.010189672	0.05801542076064135
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.010189672	0.05801542076064135
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00934579	0.05321073526121295
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00934579	0.05321073526121295
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00934579	0.05321073526121295
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.00934579	0.05321073526121295
OTOSCLEROSIS	0.00934579	0.05321073526121295
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00934579	0.05321073526121295
TREACHER COLLINS SYNDROME 3; TCS3	0.00934579	0.05321073526121295
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00934579	0.05321073526121295
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00934579	0.05321073526121295
CROUZON SYNDROME	0.00934579	0.05321073526121295
RHYNS SYNDROME; RHYNS	0.00934579	0.05321073526121295
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00934579	0.05321073526121295
#607842 AURAL ATRESIA, CONGENITAL; CAA;;AURAL ATRESIA, CONGENITAL, WITH HYPOSMIA	0.00934579	0.05321073526121295
TREACHER COLLINS SYNDROME 2; TCS2	0.00934579	0.05321073526121295
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00934579	0.05321073526121295
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00934579	0.05321073526121295
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00934579	0.05321073526121295
AGNATHIA-OTOCEPHALY COMPLEX	0.00934579	0.05321073526121295
CILIARY DYSKINESIA, PRIMARY, 33	0.00934579	0.05321073526121295
DIAMOND-BLACKFAN ANEMIA 10	0.00934579	0.05321073526121295
PARAGANGLIOMAS 1	0.00934579	0.05321073526121295
OTOFACIOCERVICAL SYNDROME	0.00934579	0.05321073526121295
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00934579	0.05321073526121295
%608572 BURN-MCKEOWN SYNDROME	0.00934579	0.05321073526121295
LATERAL MENINGOCELE SYNDROME	0.00934579	0.05321073526121295
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00934579	0.05321073526121295
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00934579	0.05321073526121295
FAMILIAL EXPANSILE OSTEOLYSIS	0.00934579	0.05321073526121295
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.008917792	0.05077390667097835
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.008917792	0.05077390667097835
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.008917792	0.05077390667097835
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.008662312	0.04931931817235654
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.008662312	0.04931931817235654
CHROMOSOME 1p35 DELETION SYNDROME	0.008662312	0.04931931817235654
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.008662312	0.04931931817235654
OPTIC ATROPHY 11; OPA11	0.008662312	0.04931931817235654
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.008662312	0.04931931817235654
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.008662312	0.04931931817235654
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.008662312	0.04931931817235654
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.008662312	0.04931931817235654
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.008662312	0.04931931817235654
YOU-HOOVER-FONG SYNDROME; YHFS	0.008662312	0.04931931817235654
CRANIOFRONTONASAL SYNDROME; CFNS	0.008595822	0.04894075394316692
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.008595822	0.04894075394316692
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.008595822	0.04894075394316692
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.008595822	0.04894075394316692
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.008595822	0.04894075394316692
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.008595822	0.04894075394316692
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.008413542	0.047902933403285976
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.008413542	0.047902933403285976
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.008413542	0.047902933403285976
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.008413542	0.047902933403285976
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.008413542	0.047902933403285976
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.008413542	0.047902933403285976
Pontine tegmental cap dysplasia	0.008413542	0.047902933403285976
OPTICOCOCHLEODENTATE DEGENERATION	0.007818430000000001	0.044514632672928156
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.007818430000000001	0.044514632672928156
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.007818430000000001	0.044514632672928156
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00775194	0.044136068443738526
JACOBSEN SYNDROME	0.00775194	0.044136068443738526
MICROCEPHALY-CARDIOMYOPATHY	0.00775194	0.044136068443738526
PELVIS-SHOULDER DYSPLASIA	0.00775194	0.044136068443738526
BOWEN-CONRADI SYNDROME	0.00775194	0.044136068443738526
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00775194	0.044136068443738526
SECKEL SYNDROME 5; SCKL5	0.00775194	0.044136068443738526
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.00775194	0.044136068443738526
SECKEL SYNDROME 2; SCKL2	0.00775194	0.044136068443738526
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.00775194	0.044136068443738526
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00775194	0.044136068443738526
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00775194	0.044136068443738526
WARBURG MICRO SYNDROME 3; WARBM3	0.00775194	0.044136068443738526
TETRALOGY OF FALLOT	0.00775194	0.044136068443738526
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.00775194	0.044136068443738526
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00775194	0.044136068443738526
MOLAR I REINCLUSION	0.00775194	0.044136068443738526
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.007569660000000001	0.04309824790385759
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.007569660000000001	0.04309824790385759
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.006685962	0.038066867963920635
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.006685962	0.038066867963920635
EMANUEL SYNDROME	0.006685962	0.038066867963920635
PELIZAEUS-MERZBACHER DISEASE	0.006685962	0.038066867963920635
GALACTOSE EPIMERASE DEFICIENCY	0.006437192	0.03665048319485007
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.006437192	0.03665048319485007
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.006437192	0.03665048319485007
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.006437192	0.03665048319485007
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.006437192	0.03665048319485007
NOONAN SYNDROME 6; NS6	0.006437192	0.03665048319485007
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.006437192	0.03665048319485007
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.006437192	0.03665048319485007
RICHARDS-RUNDLE SYNDROME; RRNS	0.006181712000000001	0.03519589469622827
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005869012	0.03341552118942132
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005869012	0.03341552118942132
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.005869012	0.03341552118942132
HADZISELIMOVIC SYNDROME	0.005869012	0.03341552118942132
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.005869012	0.03341552118942132
Xq28 (MECP2) duplication	0.005869012	0.03341552118942132
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.005869012	0.03341552118942132
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.005869012	0.03341552118942132
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED 98; MRX98	0.005869012	0.03341552118942132
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.005869012	0.03341552118942132
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.005869012	0.03341552118942132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.005869012	0.03341552118942132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005869012	0.03341552118942132
PEHO-LIKE SYNDROME; PEHOL	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005869012	0.03341552118942132
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.005869012	0.03341552118942132
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.005869012	0.03341552118942132
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005869012	0.03341552118942132
LISSENCEPHALY 8; LIS8	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.005869012	0.03341552118942132
AICARDI-GOUTIERES SYNDROME 7	0.005869012	0.03341552118942132
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.005869012	0.03341552118942132
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.005869012	0.03341552118942132
IMMUNODEFICIENCY 49; IMD49	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005869012	0.03341552118942132
AL-RAQAD SYNDROME; ARS	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.005869012	0.03341552118942132
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.005869012	0.03341552118942132
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.005869012	0.03341552118942132
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED 101; MRX101	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.005869012	0.03341552118942132
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.005869012	0.03341552118942132
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED 104; MRX104	0.005869012	0.03341552118942132
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005869012	0.03341552118942132
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005869012	0.03341552118942132
OROFACIODIGITAL SYNDROME XIV; OFD14	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.005869012	0.03341552118942132
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.005869012	0.03341552118942132
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.005869012	0.03341552118942132
MENTAL RETARDATION, X-LINKED 103	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.005869012	0.03341552118942132
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.005869012	0.03341552118942132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.005869012	0.03341552118942132
ANGELMAN SYNDROME	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.005869012	0.03341552118942132
MUCOLIPIDOSIS IV; ML4	0.005869012	0.03341552118942132
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005869012	0.03341552118942132
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.005869012	0.03341552118942132
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.005869012	0.03341552118942132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005869012	0.03341552118942132
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.005869012	0.03341552118942132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.005869012	0.03341552118942132
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.005869012	0.03341552118942132
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005869012	0.03341552118942132
#614970 JOUBERT SYNDROME 20; JBTS20	0.005869012	0.03341552118942132
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.005869012	0.03341552118942132
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00584208	0.03326218246449224
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00584208	0.03326218246449224
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.00584208	0.03326218246449224
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00584208	0.03326218246449224
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.00584208	0.03326218246449224
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.005593310000000001	0.03184579769542168
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.005593310000000001	0.03184579769542168
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00533783	0.030391209196799874
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00533783	0.030391209196799874
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00533783	0.030391209196799874
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00533783	0.030391209196799874
COWCHOCK SYNDROME; COWCK	0.00533783	0.030391209196799874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00502513	0.02861083568999293
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00502513	0.02861083568999293
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00502513	0.02861083568999293
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00502513	0.02861083568999293
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00502513	0.02861083568999293
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.00502513	0.02861083568999293
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00502513	0.02861083568999293
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00502513	0.02861083568999293
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00502513	0.02861083568999293
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.00502513	0.02861083568999293
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00502513	0.02861083568999293
WARBURG MICRO SYNDROME 2; WARBM2	0.00502513	0.02861083568999293
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00502513	0.02861083568999293
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00502513	0.02861083568999293
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00502513	0.02861083568999293
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00502513	0.02861083568999293
MOWAT-WILSON SYNDROME; MOWS	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00502513	0.02861083568999293
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00502513	0.02861083568999293
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00502513	0.02861083568999293
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.00502513	0.02861083568999293
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00502513	0.02861083568999293
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00502513	0.02861083568999293
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00502513	0.02861083568999293
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00502513	0.02861083568999293
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00502513	0.02861083568999293
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.003892662	0.022163070980985414
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.003892662	0.022163070980985414
ADENYLOSUCCINASE DEFICIENCY	0.003892662	0.022163070980985414
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.003892662	0.022163070980985414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.003892662	0.022163070980985414
HAREL-YOON SYNDROME; HAYOS	0.003892662	0.022163070980985414
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.003892662	0.022163070980985414
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.003892662	0.022163070980985414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.003892662	0.022163070980985414
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.003892662	0.022163070980985414
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.003892662	0.022163070980985414
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.003892662	0.022163070980985414
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.003892662	0.022163070980985414
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.003892662	0.022163070980985414
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.003892662	0.022163070980985414
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003892662	0.022163070980985414
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.003892662	0.022163070980985414
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.003892662	0.022163070980985414
CHROMOSOME 19p13.13 DELETION SYNDROME	0.003892662	0.022163070980985414
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.003892662	0.022163070980985414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.003892662	0.022163070980985414
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.003892662	0.022163070980985414
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.003892662	0.022163070980985414
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.003892662	0.022163070980985414
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.003892662	0.022163070980985414
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.003892662	0.022163070980985414
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.003892662	0.022163070980985414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.003892662	0.022163070980985414
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.003892662	0.022163070980985414
#614728 SECKEL SYNDROME 6; SCKL6	0.003892662	0.022163070980985414
FORSYTHE-WAKELING SYNDROME; FWS	0.003892662	0.022163070980985414
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.003892662	0.022163070980985414
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.003892662	0.022163070980985414
Cerebral creatine deficiency syndrome 3	0.003892662	0.022163070980985414
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.003892662	0.022163070980985414
LIG4 SYNDROME	0.003892662	0.022163070980985414
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.003892662	0.022163070980985414
DIGEORGE SYNDROME; DGS	0.003892662	0.022163070980985414
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.003892662	0.022163070980985414
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.003892662	0.022163070980985414
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.003892662	0.022163070980985414
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.003892662	0.022163070980985414
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.003892662	0.022163070980985414
Cerebral creatine deficiency syndrome 2	0.003892662	0.022163070980985414
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003892662	0.022163070980985414
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.003892662	0.022163070980985414
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.003892662	0.022163070980985414
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.003892662	0.022163070980985414
EPILEPSY, PYRIDOXINE-DEPENDENT	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.003892662	0.022163070980985414
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003892662	0.022163070980985414
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.003892662	0.022163070980985414
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.003892662	0.022163070980985414
SALLA DISEASE	0.003892662	0.022163070980985414
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.003892662	0.022163070980985414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.003892662	0.022163070980985414
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.003892662	0.022163070980985414
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.003892662	0.022163070980985414
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.003892662	0.022163070980985414
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.003892662	0.022163070980985414
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.003892662	0.022163070980985414
MENTAL RETARDATION, X-LINKED 90	0.003892662	0.022163070980985414
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.003892662	0.022163070980985414
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.003892662	0.022163070980985414
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.003892662	0.022163070980985414
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.003892662	0.022163070980985414
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.003892662	0.022163070980985414
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.003892662	0.022163070980985414
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.003892662	0.022163070980985414
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.003892662	0.022163070980985414
MEHMO SYNDROME; MEHMO	0.003892662	0.022163070980985414
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.003892662	0.022163070980985414
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.003892662	0.022163070980985414
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.003892662	0.022163070980985414
LANDAU-KLEFFNER SYNDROME	0.003892662	0.022163070980985414
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.003892662	0.022163070980985414
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.003892662	0.022163070980985414
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.003892662	0.022163070980985414
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.003892662	0.022163070980985414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.003892662	0.022163070980985414
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.003892662	0.022163070980985414
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.003892662	0.022163070980985414
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.003637182	0.020708482482363615
HYDROXYKYNURENINURIA	0.003637182	0.020708482482363615
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.003637182	0.020708482482363615
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003637182	0.020708482482363615
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.003637182	0.020708482482363615
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003637182	0.020708482482363615
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.003637182	0.020708482482363615
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003637182	0.020708482482363615
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.003637182	0.020708482482363615
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.003637182	0.020708482482363615
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.003637182	0.020708482482363615
BARDET-BIEDL SYNDROME 16; BBS16	0.003637182	0.020708482482363615
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.003637182	0.020708482482363615
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.003637182	0.020708482482363615
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.003637182	0.020708482482363615
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.003637182	0.020708482482363615
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003637182	0.020708482482363615
MEIER-GORLIN SYNDROME 7	0.003637182	0.020708482482363615
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.003637182	0.020708482482363615
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.003637182	0.020708482482363615
LYMPHEDEMA, HEREDITARY, III	0.003637182	0.020708482482363615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.003637182	0.020708482482363615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.003637182	0.020708482482363615
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.003637182	0.020708482482363615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.003637182	0.020708482482363615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.003637182	0.020708482482363615
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.003637182	0.020708482482363615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.003637182	0.020708482482363615
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.003637182	0.020708482482363615
PEROXISOME BIOGENESIS DISORDER 6B	0.0033884120000000004	0.019292097713293054
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.0033884120000000004	0.019292097713293054
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0033884120000000004	0.019292097713293054
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0033884120000000004	0.019292097713293054
VICI SYNDROME; VICIS	0.0033884120000000004	0.019292097713293054
CRANIOSYNOSTOSIS 6; CRS6	0.0033884120000000004	0.019292097713293054
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0033884120000000004	0.019292097713293054
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0033884120000000004	0.019292097713293054
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.0033884120000000004	0.019292097713293054
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.0033884120000000004	0.019292097713293054
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.0033884120000000004	0.019292097713293054
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0033884120000000004	0.019292097713293054
MICROPHTHALMIA, SYNDROMIC 3	0.0033884120000000004	0.019292097713293054
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0033884120000000004	0.019292097713293054
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0033884120000000004	0.019292097713293054
CDAGS SYNDROME	0.0033884120000000004	0.019292097713293054
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.0033884120000000004	0.019292097713293054
PEROXISOME BIOGENESIS DISORDER 5B	0.0033884120000000004	0.019292097713293054
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.0033884120000000004	0.019292097713293054
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0033884120000000004	0.019292097713293054
JOUBERT SYNDROME 21	0.0033884120000000004	0.019292097713293054
LEIGH SYNDROME; LS	0.0033884120000000004	0.019292097713293054
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0033884120000000004	0.019292097713293054
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0033884120000000004	0.019292097713293054
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0033884120000000004	0.019292097713293054
NOONAN SYNDROME 11; NS11	0.0033884120000000004	0.019292097713293054
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0033884120000000004	0.019292097713293054
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.0033884120000000004	0.019292097713293054
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.0033884120000000004	0.019292097713293054
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0033884120000000004	0.019292097713293054
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0033884120000000004	0.019292097713293054
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0033884120000000004	0.019292097713293054
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0033884120000000004	0.019292097713293054
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0033884120000000004	0.019292097713293054
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0033884120000000004	0.019292097713293054
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.0033884120000000004	0.019292097713293054
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.0033884120000000004	0.019292097713293054
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0033884120000000004	0.019292097713293054
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.0033884120000000004	0.019292097713293054
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0033884120000000004	0.019292097713293054
WAARDENBURG-SHAH SYNDROME	0.0033884120000000004	0.019292097713293054
STEEL SYNDROME; STLS	0.0033884120000000004	0.019292097713293054
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0033884120000000004	0.019292097713293054
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0033884120000000004	0.019292097713293054
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.0033884120000000004	0.019292097713293054
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.0033884120000000004	0.019292097713293054
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00304878	0.017358385481557024
VERVERI-BRADY SYNDROME; VERBRAS	0.00304878	0.017358385481557024
MENTAL RETARDATION, X-LINKED 19	0.00304878	0.017358385481557024
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00304878	0.017358385481557024
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00304878	0.017358385481557024
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00304878	0.017358385481557024
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00304878	0.017358385481557024
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00304878	0.017358385481557024
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00304878	0.017358385481557024
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00304878	0.017358385481557024
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00304878	0.017358385481557024
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00304878	0.017358385481557024
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00304878	0.017358385481557024
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00304878	0.017358385481557024
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00304878	0.017358385481557024
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00304878	0.017358385481557024
22q11 deletion syndrome (Velocardiofacial / DiGeorge syndrome)	0.00304878	0.017358385481557024
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00304878	0.017358385481557024
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.00304878	0.017358385481557024
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00304878	0.017358385481557024
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00304878	0.017358385481557024
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00304878	0.017358385481557024
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00304878	0.017358385481557024
CHROMOSOME 13q14 DELETION SYNDROME	0.00304878	0.017358385481557024
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.00304878	0.017358385481557024
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00304878	0.017358385481557024
RETINITIS PIGMENTOSA 71; RP71	0.00304878	0.017358385481557024
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00304878	0.017358385481557024
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00304878	0.017358385481557024
CHITAYAT SYNDROME	0.00304878	0.017358385481557024
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00304878	0.017358385481557024
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.00304878	0.017358385481557024
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00304878	0.017358385481557024
HYPOGLOSSIA WITH SITUS INVERSUS	0.00304878	0.017358385481557024
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.00304878	0.017358385481557024
DYSTONIA 16; DYT16	0.00304878	0.017358385481557024
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00304878	0.017358385481557024
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00304878	0.017358385481557024
MAXILLOFACIAL DYSOSTOSIS	0.00304878	0.017358385481557024
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00304878	0.017358385481557024
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00304878	0.017358385481557024
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00304878	0.017358385481557024
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00304878	0.017358385481557024
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00304878	0.017358385481557024
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00304878	0.017358385481557024
AUTISM	0.00304878	0.017358385481557024
7q11.23 duplication syndrome	0.00304878	0.017358385481557024
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00304878	0.017358385481557024
224550 DYSTONIA WITH RINGBINDEN	0.00304878	0.017358385481557024
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00304878	0.017358385481557024
8p23.1 duplication syndrome	0.00304878	0.017358385481557024
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00304878	0.017358385481557024
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00304878	0.017358385481557024
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00304878	0.017358385481557024
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.00304878	0.017358385481557024
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00304878	0.017358385481557024
FG SYNDROME 2; FGS2	0.00304878	0.017358385481557024
HYPERLYSINEMIA, TYPE I	0.00304878	0.017358385481557024
MEIER-GORLIN SYNDROME 3; MGORS3	0.00304878	0.017358385481557024
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00304878	0.017358385481557024
MENTAL RETARDATION, X-LINKED 95	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00304878	0.017358385481557024
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00304878	0.017358385481557024
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00304878	0.017358385481557024
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00304878	0.017358385481557024
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00304878	0.017358385481557024
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00304878	0.017358385481557024
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00304878	0.017358385481557024
ASPARTYLGLUCOSAMINURIA; AGU	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00304878	0.017358385481557024
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00304878	0.017358385481557024
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00304878	0.017358385481557024
CRANIOSYNOSTOSIS 7	0.00304878	0.017358385481557024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00304878	0.017358385481557024
MENTAL RETARDATION, X-LINKED 93	0.00304878	0.017358385481557024
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00304878	0.017358385481557024
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.0027933000000000003	0.01590379698293522
ANUS, IMPERFORATE	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.0027933000000000003	0.01590379698293522
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.0027933000000000003	0.01590379698293522
TUNE DEAFNESS	0.0027933000000000003	0.01590379698293522
#614899 DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93	0.0027933000000000003	0.01590379698293522
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.01590379698293522
USHER SYNDROME, TYPE IID; USH2D	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.0027933000000000003	0.01590379698293522
BRANCHIOOTIC SYNDROME 2	0.0027933000000000003	0.01590379698293522
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0027933000000000003	0.01590379698293522
SPINOCEREBELLAR ATAXIA 13	0.0027933000000000003	0.01590379698293522
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0027933000000000003	0.01590379698293522
XFE PROGEROID SYNDROME; XFEPS	0.0027933000000000003	0.01590379698293522
BARAITSER-WINTER SYNDROME 2; BRWS2	0.0027933000000000003	0.01590379698293522
NATHALIE SYNDROME	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.0027933000000000003	0.01590379698293522
NEUROFIBROMATOSIS, TYPE II	0.0027933000000000003	0.01590379698293522
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL DOMINANT 24	0.0027933000000000003	0.01590379698293522
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.0027933000000000003	0.01590379698293522
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.0027933000000000003	0.01590379698293522
#600971 DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6	0.0027933000000000003	0.01590379698293522
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.0027933000000000003	0.01590379698293522
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.0027933000000000003	0.01590379698293522
WILDERVANCK SYNDROME	0.0027933000000000003	0.01590379698293522
MENIERE DISEASE	0.0027933000000000003	0.01590379698293522
MENTAL RETARDATION, X-LINKED 102	0.0027933000000000003	0.01590379698293522
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0027933000000000003	0.01590379698293522
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0027933000000000003	0.01590379698293522
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0027933000000000003	0.01590379698293522
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0027933000000000003	0.01590379698293522
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0027933000000000003	0.01590379698293522
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0027933000000000003	0.01590379698293522
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.01590379698293522
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0027933000000000003	0.01590379698293522
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0027933000000000003	0.01590379698293522
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.0027933000000000003	0.01590379698293522
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.0027933000000000003	0.01590379698293522
GLYCOGEN STORAGE DISEASE II	0.0027933000000000003	0.01590379698293522
SPASTIC PARAPARESIS AND DEAFNESS	0.0027933000000000003	0.01590379698293522
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027933000000000003	0.01590379698293522
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.0027933000000000003	0.01590379698293522
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0027933000000000003	0.01590379698293522
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0027933000000000003	0.01590379698293522
#612645 DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	0.0027933000000000003	0.01590379698293522
#602459 DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	0.0027933000000000003	0.01590379698293522
DEAFNESS-CRANIOFACIAL SYNDROME	0.0027933000000000003	0.01590379698293522
USHER SYNDROME, TYPE ID	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.0027933000000000003	0.01590379698293522
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.0027933000000000003	0.01590379698293522
PAGET DISEASE OF BONE 4; PDB4	0.0027933000000000003	0.01590379698293522
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0027933000000000003	0.01590379698293522
N SYNDROME	0.0027933000000000003	0.01590379698293522
CONE-ROD DYSTROPHY 1; CORD1	0.0027933000000000003	0.01590379698293522
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0027933000000000003	0.01590379698293522
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.0027933000000000003	0.01590379698293522
RETINAL VENOUS BEADING	0.0027933000000000003	0.01590379698293522
DEAFNESS, X-LINKED 5; DFNX5	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.0027933000000000003	0.01590379698293522
ABCD SYNDROME	0.0027933000000000003	0.01590379698293522
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0027933000000000003	0.01590379698293522
#615629 DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56	0.0027933000000000003	0.01590379698293522
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.0027933000000000003	0.01590379698293522
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0027933000000000003	0.01590379698293522
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.01590379698293522
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.0027933000000000003	0.01590379698293522
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.0027933000000000003	0.01590379698293522
#300914 DEAFNESS, X-LINKED 6; DFNX6	0.0027933000000000003	0.01590379698293522
RAMON SYNDROME	0.0027933000000000003	0.01590379698293522
KRABBE DISEASE	0.0027933000000000003	0.01590379698293522
#615429 DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88	0.0027933000000000003	0.01590379698293522
CYCLIC VOMITING SYNDROME	0.0027933000000000003	0.01590379698293522
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.0027933000000000003	0.01590379698293522
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0027933000000000003	0.01590379698293522
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0027933000000000003	0.01590379698293522
OTOSCLEROSIS 3; OTSC3	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.0027933000000000003	0.01590379698293522
DYSOSTEOSCLEROSIS	0.0027933000000000003	0.01590379698293522
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0027933000000000003	0.01590379698293522
CHIARI MALFORMATION TYPE I	0.0027933000000000003	0.01590379698293522
CHARGE-LIKE SYNDROME, X-LINKED	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.0027933000000000003	0.01590379698293522
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.0027933000000000003	0.01590379698293522
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0027933000000000003	0.01590379698293522
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.0027933000000000003	0.01590379698293522
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.0027933000000000003	0.01590379698293522
AUROCEPHALOSYNDACTYLY	0.0027933000000000003	0.01590379698293522
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.0027933000000000003	0.01590379698293522
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0027933000000000003	0.01590379698293522
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0027933000000000003	0.01590379698293522
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.0027933000000000003	0.01590379698293522
#614614 DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	0.0027933000000000003	0.01590379698293522
BRITTLE CORNEA SYNDROME 2; BCS2	0.0027933000000000003	0.01590379698293522
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.0027933000000000003	0.01590379698293522
CANAVAN DISEASE	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.0027933000000000003	0.01590379698293522
#614934 DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70	0.0027933000000000003	0.01590379698293522
CAMURATI-ENGELMANN DISEASE	0.0027933000000000003	0.01590379698293522
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.0027933000000000003	0.01590379698293522
EAR EXOSTOSES	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.0027933000000000003	0.01590379698293522
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0027933000000000003	0.01590379698293522
Adrenoleukodystrophy	0.0027933000000000003	0.01590379698293522
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.0027933000000000003	0.01590379698293522
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.0027933000000000003	0.01590379698293522
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.0027933000000000003	0.01590379698293522
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0027933000000000003	0.01590379698293522
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0027933000000000003	0.01590379698293522
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0027933000000000003	0.01590379698293522
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0027933000000000003	0.01590379698293522
COXOAURICULAR SYNDROME	0.0027933000000000003	0.01590379698293522
PAGET DISEASE OF BONE 3; PDB3	0.0027933000000000003	0.01590379698293522
#613558 DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51;;CHROMOSOME 9Q21.11 DUPLICATION SYNDROME	0.0027933000000000003	0.01590379698293522
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0027933000000000003	0.01590379698293522
DEMENTIA, FAMILIAL DANISH	0.0027933000000000003	0.01590379698293522
#614944 DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B	0.0027933000000000003	0.01590379698293522
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.01590379698293522
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.0027933000000000003	0.01590379698293522
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0027933000000000003	0.01590379698293522
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0027933000000000003	0.01590379698293522
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.0027933000000000003	0.01590379698293522
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027933000000000003	0.01590379698293522
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.0027933000000000003	0.01590379698293522
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0027933000000000003	0.01590379698293522
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.0027933000000000003	0.01590379698293522
#614896 SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	0.0027933000000000003	0.01590379698293522
FETAL IODINE DEFICIENCY DISORDER	0.0027933000000000003	0.01590379698293522
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.0027933000000000003	0.01590379698293522
#610896 BRANCHIOOTORENAL SYNDROME 2; BOR2	0.0027933000000000003	0.01590379698293522
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.0027933000000000003	0.01590379698293522
HARDIKAR SYNDROME	0.0027933000000000003	0.01590379698293522
OTOSCLEROSIS 8; OTSC8	0.0027933000000000003	0.01590379698293522
LISSENCEPHALY 5; LIS5	0.0027933000000000003	0.01590379698293522
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0027933000000000003	0.01590379698293522
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0027933000000000003	0.01590379698293522
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0027933000000000003	0.01590379698293522
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.0027933000000000003	0.01590379698293522
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0027933000000000003	0.01590379698293522
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0027933000000000003	0.01590379698293522
OSTEOGENESIS IMPERFECTA, TYPE I	0.0027933000000000003	0.01590379698293522
XYLOSIDASE DEFICIENCY	0.0027933000000000003	0.01590379698293522
PULMONIC STENOSIS AND DEAFNESS	0.0027933000000000003	0.01590379698293522
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.0027933000000000003	0.01590379698293522
#613718 DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	0.0027933000000000003	0.01590379698293522
BARBER-SAY SYNDROME; BBRSAY	0.0027933000000000003	0.01590379698293522
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0027933000000000003	0.01590379698293522
WOODHOUSE-SAKATI SYNDROME	0.00254453	0.014487412213864658
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00254453	0.014487412213864658
#220290 DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1ADEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;;DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED	0.00254453	0.014487412213864658
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00254453	0.014487412213864658
ERMINE PHENOTYPE	0.00254453	0.014487412213864658
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00254453	0.014487412213864658
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00254453	0.014487412213864658
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00254453	0.014487412213864658
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00254453	0.014487412213864658
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.00254453	0.014487412213864658
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00254453	0.014487412213864658
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00254453	0.014487412213864658
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.00254453	0.014487412213864658
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00254453	0.014487412213864658
#608565 DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35	0.00254453	0.014487412213864658
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00254453	0.014487412213864658
CHANARIN-DORFMAN SYNDROME	0.00254453	0.014487412213864658
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00254453	0.014487412213864658
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00254453	0.014487412213864658
#616357 DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40	0.00254453	0.014487412213864658
#607841 DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48	0.00254453	0.014487412213864658
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00254453	0.014487412213864658
#616340 DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67	0.00254453	0.014487412213864658
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00254453	0.014487412213864658
PERRAULT SYNDROME 2; PRLTS2	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00254453	0.014487412213864658
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00254453	0.014487412213864658
#606705 DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00254453	0.014487412213864658
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00254453	0.014487412213864658
KEARNS-SAYRE SYNDROME; KSS	0.00254453	0.014487412213864658
ENLARGED VESTIBULAR AQUEDUCT	0.00254453	0.014487412213864658
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00254453	0.014487412213864658
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00254453	0.014487412213864658
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00254453	0.014487412213864658
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00254453	0.014487412213864658
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00254453	0.014487412213864658
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00254453	0.014487412213864658
STICKLER SYNDROME, TYPE V; STL5	0.00254453	0.014487412213864658
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00254453	0.014487412213864658
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00254453	0.014487412213864658
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00254453	0.014487412213864658
#614861 DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00254453	0.014487412213864658
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00254453	0.014487412213864658
DEAFNESS, X-LINKED 1	0.00254453	0.014487412213864658
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.00254453	0.014487412213864658
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00254453	0.014487412213864658
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00254453	0.014487412213864658
#613865 DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61	0.00254453	0.014487412213864658
#610220 DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59	0.00254453	0.014487412213864658
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00254453	0.014487412213864658
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.00254453	0.014487412213864658
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00254453	0.014487412213864658
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00254453	0.014487412213864658
Deafness, autosomal recessive 99	0.00254453	0.014487412213864658
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00254453	0.014487412213864658
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00254453	0.014487412213864658
DYSTONIA, JUVENILE-ONSET	0.00254453	0.014487412213864658
#607039 DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22	0.00254453	0.014487412213864658
#607453 DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44	0.00254453	0.014487412213864658
DEAFNESS, Y-LINKED 1	0.00254453	0.014487412213864658
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00254453	0.014487412213864658
WOLFRAM SYNDROME 2; WFS2	0.00254453	0.014487412213864658
#234580 HEIMLER SYNDROME 1; HMLR1;;HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS;;PEROXISOME BIOGENESIS DISORDER 1C; PBD1C	0.00254453	0.014487412213864658
OPTIC ATROPHY 8	0.00254453	0.014487412213864658
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00254453	0.014487412213864658
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00254453	0.014487412213864658
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00254453	0.014487412213864658
#154780 MARSHALL SYNDROME; MRSHS	0.00254453	0.014487412213864658
MENTAL RETARDATION, X-LINKED 46	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00254453	0.014487412213864658
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00254453	0.014487412213864658
#609006 DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT, INCLUDED	0.00254453	0.014487412213864658
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00254453	0.014487412213864658
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00254453	0.014487412213864658
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00254453	0.014487412213864658
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00254453	0.014487412213864658
#607084 DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31;;WHIRLER, MOUSE, HOMOLOG OF	0.00254453	0.014487412213864658
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00254453	0.014487412213864658
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00254453	0.014487412213864658
#603629 DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21	0.00254453	0.014487412213864658
DEAFNESS, Y-LINKED 2; DFNY2	0.00254453	0.014487412213864658
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.00254453	0.014487412213864658
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00254453	0.014487412213864658
RETINITIS PIGMENTOSA 59; RP59	0.00254453	0.014487412213864658
DE SANCTIS-CACCHIONE SYNDROME	0.00254453	0.014487412213864658
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.00254453	0.014487412213864658
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00254453	0.014487412213864658
USHER SYNDROME, TYPE IIIA	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00254453	0.014487412213864658
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00254453	0.014487412213864658
#609057 NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	0.00254453	0.014487412213864658
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00254453	0.014487412213864658
HYPERLEUCINE-ISOLEUCINEMIA	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00254453	0.014487412213864658
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00254453	0.014487412213864658
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00254453	0.014487412213864658
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00254453	0.014487412213864658
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00254453	0.014487412213864658
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00254453	0.014487412213864658
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00254453	0.014487412213864658
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00254453	0.014487412213864658
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00254453	0.014487412213864658
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00254453	0.014487412213864658
Deafness, autosomal recessive 113	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00254453	0.014487412213864658
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00254453	0.014487412213864658
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00254453	0.014487412213864658
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00254453	0.014487412213864658
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00254453	0.014487412213864658
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00254453	0.014487412213864658
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00254453	0.014487412213864658
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00254453	0.014487412213864658
#608389 BRANCHIOOTIC SYNDROME 3; BOS3;;BO SYNDROME 3	0.00254453	0.014487412213864658
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00254453	0.014487412213864658
PAPILLORENAL SYNDROME	0.00254453	0.014487412213864658
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00254453	0.014487412213864658
REFSUM DISEASE	0.00254453	0.014487412213864658
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00254453	0.014487412213864658
#613707 LEOPARD SYNDROME 3; LPRD3	0.00254453	0.014487412213864658
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.00254453	0.014487412213864658
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00254453	0.014487412213864658
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00254453	0.014487412213864658
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00254453	0.014487412213864658
SPINOCEREBELLAR ATAXIA 31	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00254453	0.014487412213864658
#609706 DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53	0.00254453	0.014487412213864658
USHER SYNDROME, TYPE IG	0.00254453	0.014487412213864658
THYROCEREBRORETINAL SYNDROME	0.00254453	0.014487412213864658
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00254453	0.014487412213864658
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00254453	0.014487412213864658
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00254453	0.014487412213864658
IMMUNODEFICIENCY 47	0.00254453	0.014487412213864658
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00254453	0.014487412213864658
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00254453	0.014487412213864658
#602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME	0.00254453	0.014487412213864658
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00254453	0.014487412213864658
STICKLER SYNDROME, TYPE III	0.00254453	0.014487412213864658
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00254453	0.014487412213864658
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00254453	0.014487412213864658
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00254453	0.014487412213864658
NEURAMINIDASE DEFICIENCY	0.00254453	0.014487412213864658
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00254453	0.014487412213864658
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00254453	0.014487412213864658
ALPORT SYNDROME, X-LINKED; ATS	0.00254453	0.014487412213864658
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00254453	0.014487412213864658
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00254453	0.014487412213864658
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00254453	0.014487412213864658
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00254453	0.014487412213864658
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00254453	0.014487412213864658
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00254453	0.014487412213864658
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.00254453	0.014487412213864658
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00254453	0.014487412213864658
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00254453	0.014487412213864658
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.00254453	0.014487412213864658
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00254453	0.014487412213864658
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00254453	0.014487412213864658
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000843882	0.004804685499428395
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.004804685499428395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000843882	0.004804685499428395
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.004804685499428395
OCULOECTODERMAL SYNDROME; OES	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.004804685499428395
SECKEL SYNDROME 9; SCKL9	0.000843882	0.004804685499428395
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.004804685499428395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000843882	0.004804685499428395
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.004804685499428395
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.004804685499428395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000843882	0.004804685499428395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000843882	0.004804685499428395
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.004804685499428395
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.004804685499428395
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.004804685499428395
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.004804685499428395
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.004804685499428395
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.004804685499428395
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.004804685499428395
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.004804685499428395
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.004804685499428395
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000843882	0.004804685499428395
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.004804685499428395
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.004804685499428395
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.004804685499428395
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.004804685499428395
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000843882	0.004804685499428395
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.004804685499428395
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.004804685499428395
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.004804685499428395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.004804685499428395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000843882	0.004804685499428395
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000843882	0.004804685499428395
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.000843882	0.004804685499428395
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000843882	0.004804685499428395
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000843882	0.004804685499428395
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.004804685499428395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000843882	0.004804685499428395
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.000843882	0.004804685499428395
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.004804685499428395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000843882	0.004804685499428395
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.004804685499428395
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.004804685499428395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000843882	0.004804685499428395
TYSHCHENKO SYNDROME	0.000843882	0.004804685499428395
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.004804685499428395
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.004804685499428395
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.004804685499428395
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.004804685499428395
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000843882	0.004804685499428395
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000843882	0.004804685499428395
OGDEN SYNDROME; OGDNS	0.000843882	0.004804685499428395
LISSENCEPHALY 2; LIS2	0.000843882	0.004804685499428395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000843882	0.004804685499428395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.004804685499428395
NIEMANN-PICK DISEASE, TYPE C2	0.000843882	0.004804685499428395
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.000843882	0.004804685499428395
300270 ADRENOMYODYSTROPHY	0.000843882	0.004804685499428395
TIMOTHY SYNDROME; TS	0.000843882	0.004804685499428395
MEVALONIC ACIDURIA; MEVA	0.000843882	0.004804685499428395
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.004804685499428395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000843882	0.004804685499428395
LISSENCEPHALY 1; LIS1	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000843882	0.004804685499428395
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000843882	0.004804685499428395
RAHMAN SYNDROME	0.000843882	0.004804685499428395
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000843882	0.004804685499428395
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.004804685499428395
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.004804685499428395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000843882	0.004804685499428395
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.000843882	0.004804685499428395
JOUBERT SYNDROME 25	0.000843882	0.004804685499428395
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000843882	0.004804685499428395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000843882	0.004804685499428395
TEMTAMY SYNDROME; TEMTYS	0.000843882	0.004804685499428395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.004804685499428395
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000843882	0.004804685499428395
NIEMANN-PICK DISEASE, TYPE A	0.000843882	0.004804685499428395
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.004804685499428395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000843882	0.004804685499428395
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000843882	0.004804685499428395
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000843882	0.004804685499428395
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000843882	0.004804685499428395
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.000843882	0.004804685499428395
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.004804685499428395
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.004804685499428395
PELLAGRA-LIKE SYNDROME	0.000843882	0.004804685499428395
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.004804685499428395
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000843882	0.004804685499428395
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000843882	0.004804685499428395
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000843882	0.004804685499428395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000843882	0.004804685499428395
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.004804685499428395
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.004804685499428395
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000843882	0.004804685499428395
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000843882	0.004804685499428395
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.004804685499428395
PROPIONIC ACIDEMIA	0.000843882	0.004804685499428395
SECKEL SYNDROME 8; SCKL8	0.000843882	0.004804685499428395
JOUBERT SYNDROME 8	0.000843882	0.004804685499428395
GLYCEROL KINASE DEFICIENCY; GKD	0.000843882	0.004804685499428395
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000843882	0.004804685499428395
LOWRY-MACLEAN SYNDROME	0.000843882	0.004804685499428395
HOLOPROSENCEPHALY 2; HPE2	0.000843882	0.004804685499428395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.004804685499428395
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.004804685499428395
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.000843882	0.004804685499428395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000843882	0.004804685499428395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000843882	0.004804685499428395
JOUBERT SYNDROME 10	0.000843882	0.004804685499428395
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.004804685499428395
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.000843882	0.004804685499428395
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.004804685499428395
ADAMS-OLIVER SYNDROME 1; AOS1	0.000843882	0.004804685499428395
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.004804685499428395
XIA-GIBBS SYNDROME	0.000843882	0.004804685499428395
GABA-TRANSAMINASE DEFICIENCY	0.000843882	0.004804685499428395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.004804685499428395
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000843882	0.004804685499428395
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.004804685499428395
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000843882	0.004804685499428395
DYSTONIA 28, CHILDHOOD-ONSET	0.000843882	0.004804685499428395
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.000843882	0.004804685499428395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000843882	0.004804685499428395
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.004804685499428395
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000843882	0.004804685499428395
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.004804685499428395
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.004804685499428395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000843882	0.004804685499428395
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.004804685499428395
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.004804685499428395
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.000843882	0.004804685499428395
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000843882	0.004804685499428395
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000843882	0.004804685499428395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000843882	0.004804685499428395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000843882	0.004804685499428395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000843882	0.004804685499428395
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.004804685499428395
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.004804685499428395
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.004804685499428395
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.004804685499428395
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.000843882	0.004804685499428395
EVEN-PLUS SYNDROME	0.000843882	0.004804685499428395
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.004804685499428395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000843882	0.004804685499428395
NOONAN SYNDROME 3; NS3	0.000843882	0.004804685499428395
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.004804685499428395
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.004804685499428395
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.004804685499428395
JOUBERT SYNDROME 26	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.004804685499428395
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000843882	0.004804685499428395
JOUBERT SYNDROME 6	0.000843882	0.004804685499428395
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000843882	0.004804685499428395
SCHINDLER DISEASE, TYPE I	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.004804685499428395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.004804685499428395
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000843882	0.004804685499428395
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000843882	0.004804685499428395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.004804685499428395
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.004804685499428395
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000843882	0.004804685499428395
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.004804685499428395
WAISMAN SYNDROME; WSMN	0.000843882	0.004804685499428395
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000843882	0.004804685499428395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.004804685499428395
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000843882	0.004804685499428395
WEBB-DATTANI SYNDROME; WEDAS	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000843882	0.004804685499428395
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000843882	0.004804685499428395
JOUBERT SYNDROME 35; JBTS35	0.000843882	0.004804685499428395
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.004804685499428395
SENIOR-LOKEN SYNDROME 9	0.000843882	0.004804685499428395
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.004804685499428395
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000843882	0.004804685499428395
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.004804685499428395
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000843882	0.004804685499428395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000843882	0.004804685499428395
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.004804685499428395
HARTSFIELD SYNDROME; HRTFDS	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.004804685499428395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000843882	0.004804685499428395
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000843882	0.004804685499428395
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.004804685499428395
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.004804685499428395
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000843882	0.004804685499428395
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.004804685499428395
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000843882	0.004804685499428395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000843882	0.004804685499428395
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000843882	0.004804685499428395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000843882	0.004804685499428395
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000843882	0.004804685499428395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.004804685499428395
REVESZ SYNDROME	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000843882	0.004804685499428395
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.004804685499428395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.004804685499428395
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000843882	0.004804685499428395
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000843882	0.004804685499428395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000843882	0.004804685499428395
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000843882	0.004804685499428395
#300555 DENT DISEASE 2	0.000843882	0.004804685499428395
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.004804685499428395
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.004804685499428395
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000843882	0.004804685499428395
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.004804685499428395
INFANTILE SIALIC ACID STORAGE DISEASE	0.000843882	0.004804685499428395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000843882	0.004804685499428395
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000843882	0.004804685499428395
AUSTRALIA ANTIGEN	0.000843882	0.004804685499428395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000843882	0.004804685499428395
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000843882	0.004804685499428395
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.004804685499428395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000843882	0.004804685499428395
#170100 PROLIDASE DEFICIENCY	0.000843882	0.004804685499428395
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.004804685499428395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.004804685499428395
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.004804685499428395
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000843882	0.004804685499428395
JOUBERT SYNDROME 27	0.000843882	0.004804685499428395
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.004804685499428395
ELEJALDE DISEASE	0.000843882	0.004804685499428395
BETA-UREIDOPROPIONASE DEFICIENCY	0.000843882	0.004804685499428395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000843882	0.004804685499428395
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.004804685499428395
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000843882	0.004804685499428395
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.004804685499428395
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.004804685499428395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000843882	0.004804685499428395
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.004804685499428395
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.004804685499428395
NOONAN SYNDROME 5; NS5	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000843882	0.004804685499428395
JOUBERT SYNDROME 28	0.000843882	0.004804685499428395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000843882	0.004804685499428395
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000843882	0.004804685499428395
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.004804685499428395
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.004804685499428395
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.004804685499428395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000843882	0.004804685499428395
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000843882	0.004804685499428395
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.004804685499428395
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000843882	0.004804685499428395
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.004804685499428395
CITRULLINEMIA, CLASSIC	0.000843882	0.004804685499428395
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.000843882	0.004804685499428395
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.004804685499428395
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.004804685499428395
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.004804685499428395
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.004804685499428395
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.004804685499428395
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.004804685499428395
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000843882	0.004804685499428395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000843882	0.004804685499428395
FUMARASE DEFICIENCY; FMRD	0.000843882	0.004804685499428395
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000843882	0.004804685499428395
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.004804685499428395
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000843882	0.004804685499428395
GAUCHER DISEASE, TYPE II	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.004804685499428395
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.004804685499428395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.004804685499428395
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.004804685499428395
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.004804685499428395
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.000843882	0.004804685499428395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000843882	0.004804685499428395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.004804685499428395
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.004804685499428395
PHACE ASSOCIATION	0.000843882	0.004804685499428395
PYRUVATE CARBOXYLASE DEFICIENCY	0.000843882	0.004804685499428395
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.004804685499428395
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.004804685499428395
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000843882	0.004804685499428395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.004804685499428395
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000843882	0.004804685499428395
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.004804685499428395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.004804685499428395
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.000843882	0.004804685499428395
ALAZAMI SYNDROME; ALAZS	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000843882	0.004804685499428395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000843882	0.004804685499428395
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000843882	0.004804685499428395
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.000843882	0.004804685499428395
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000843882	0.004804685499428395
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.004804685499428395
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.004804685499428395
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000843882	0.004804685499428395
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000843882	0.004804685499428395
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.004804685499428395
GRACILE BONE DYSPLASIA; GCLEB	0.000843882	0.004804685499428395
NETHERTON SYNDROME; NETH	0.000843882	0.004804685499428395
LISSENCEPHALY 4	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000843882	0.004804685499428395
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.004804685499428395
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.004804685499428395
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.004804685499428395
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000843882	0.004804685499428395
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000843882	0.004804685499428395
HOLOPROSENCEPHALY 7	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.004804685499428395
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.004804685499428395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000843882	0.004804685499428395
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000843882	0.004804685499428395
CULLER-JONES SYNDROME; CJS	0.000843882	0.004804685499428395
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.004804685499428395
NOONAN SYNDROME 9; NS9	0.000843882	0.004804685499428395
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.004804685499428395
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.004804685499428395
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.004804685499428395
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000843882	0.004804685499428395
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.000843882	0.004804685499428395
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.004804685499428395
JOUBERT SYNDROME 15	0.000843882	0.004804685499428395
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.004804685499428395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000843882	0.004804685499428395
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.004804685499428395
FRONTOOCULAR SYNDROME	0.000843882	0.004804685499428395
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.000843882	0.004804685499428395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000843882	0.004804685499428395
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.004804685499428395
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000843882	0.004804685499428395
OROTIC ACIDURIA	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.000843882	0.004804685499428395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.004804685499428395
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000843882	0.004804685499428395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.004804685499428395
RING CHROMOSOME 14 SYNDROME	0.000843882	0.004804685499428395
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.004804685499428395
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.004804685499428395
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000843882	0.004804685499428395
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.004804685499428395
FRIAS SYNDROME	0.000843882	0.004804685499428395
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.004804685499428395
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000843882	0.004804685499428395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000843882	0.004804685499428395
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.004804685499428395
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.004804685499428395
HARTNUP DISORDER	0.000843882	0.004804685499428395
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.004804685499428395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000843882	0.004804685499428395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000843882	0.004804685499428395
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000843882	0.004804685499428395
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.004804685499428395
Leukotriene C4 synthase deficiency	0.000843882	0.004804685499428395
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.004804685499428395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000843882	0.004804685499428395
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.004804685499428395
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.000843882	0.004804685499428395
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000843882	0.004804685499428395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.000843882	0.004804685499428395
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.004804685499428395
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000843882	0.004804685499428395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.000843882	0.004804685499428395
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000843882	0.004804685499428395
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.004804685499428395
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000843882	0.004804685499428395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000843882	0.004804685499428395
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.004804685499428395
SULFOCYSTEINURIA	0.000843882	0.004804685499428395
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.000843882	0.004804685499428395
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000843882	0.004804685499428395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000843882	0.004804685499428395
JOUBERT SYNDROME 14	0.000843882	0.004804685499428395
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.004804685499428395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.004804685499428395
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.004804685499428395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.004804685499428395
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.004804685499428395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000843882	0.004804685499428395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.004804685499428395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000843882	0.004804685499428395
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.004804685499428395
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.004804685499428395
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.004804685499428395
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000843882	0.004804685499428395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.004804685499428395
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000843882	0.004804685499428395
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000843882	0.004804685499428395
MECKEL SYNDROME 13; MKS13	0.000843882	0.004804685499428395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000843882	0.004804685499428395
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.004804685499428395
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000843882	0.004804685499428395
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.000843882	0.004804685499428395
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.004804685499428395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.000843882	0.004804685499428395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.004804685499428395
CURRARINO SYNDROME	0.000843882	0.004804685499428395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.004804685499428395
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000843882	0.004804685499428395
NOONAN SYNDROME 2; NS2	0.000843882	0.004804685499428395
ARGININOSUCCINIC ACIDURIA	0.000843882	0.004804685499428395
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000843882	0.004804685499428395
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.004804685499428395
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000843882	0.004804685499428395
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000843882	0.004804685499428395
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.004804685499428395
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.004804685499428395
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.004804685499428395
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000843882	0.004804685499428395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000843882	0.004804685499428395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000843882	0.004804685499428395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000843882	0.004804685499428395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000843882	0.004804685499428395
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000843882	0.004804685499428395
HOLOPROSENCEPHALY 1; HPE1	0.000843882	0.004804685499428395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000843882	0.004804685499428395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.004804685499428395
